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Abstract 
Antihypertensive treatment is an important challenge and public health issue, compliance 
to treatment of hypertension is one of the important factors that affect blood pressure 
control, no enough studies had been done about this issue in Palestine. In this study 
compliance to drug and lifestyle modification treatment were investigated. 
The aim of this study was to assess the factors affecting compliance to antihypertensive 
drug treatment and recommended lifestyle modifications among hypertensive Palestinian 
patients attending primary health care clinics in Bethlehem district. 
A descriptive cross sectional design was applied on systematic random sampling, sample 
of 300 hypertension participant at UNRWA, Government, and Non-Governmental clinic, 
using an interviewer administrated close ended questionnaire which depended on Health 
Belief Model. The questionnaires were filled face to face, the response rate was 100% in 
all clinics, Data analysis was done using (SPSS) version 19 to measure compliance on a 4-
point Likert scale. 
The most important findings were (65.6%) of the participants were female, and (34.3%) 
were male, participants had a range age of (28-80). Among  the total respondents (32.6%) 
didn’t had any complications, (67.1%) had one problems or more related to hypertension, 
the majority of the respondents took one to three medication (96%), ( 0.7%) didn't had any  
medications. (99.1%) took one to three doses of medication per day, (69.3%) of the total 
respondents didn't skip any dose and (30.7%) skipped one or more dose. 
And there was a strong significant association between doses skipped per day (p-value = 
0.000) perception of severity (p-value = 0.003), perception of barriers (p-value = 0.000) 
and internal factors (p-value = 0.001) of total respondents and treatment compliance. For 
xiii 
UNRWA respondents there was significant relationship between gender (p-value =0.035), 
doses skipped in the last three days (p-value =0.035), perception of barriers (p-value 
=0.001), internal factors (p-value = 0.011) and treatment compliance. For the government 
respondents there was significant association between doses skipped in the last three days 
(p-value = 0.000) and body mass index (p-value = 0.013), perception of severity (p-value = 
0.039), perception of barriers (p-value = 0.008), cues to action (p-value = 0.019) and 
treatment compliance. For the NGO there was association between educational status(p-
value = 0.037)and occupational status (p-value = 0.03), perception of barriers (p-value 
=0.024), internal factors(p-value = 0.008) and treatment compliance.  
The best predictor variables for treatment compliance were perception of barriers, 
perception of internal factors and perception of severity of total respondents. For UNRWA 
respondents the best predictor variables were perception of barriers and perception of 
internal factors. For Government respondents the best predictive variables were perception 
of barriers and cues to action. For NGOs the best predictive variables were internal factors 
and perception of barriers. 
This study concluded that the most important factors affected treatment compliance of the 
respondents were doses skipped, gender, body mass index, educational status, occupational 
status, perception of severity, perception of barriers, cues to action and internal factors. 
This study concluded that the total respondents were compliance to their drug treatment 
and lifestyle modification, NGOs respondent were more compliant than UNRWA and 
Government respondents in drug treatment while Government and UNRWA were more 
compliant than NGOs in lifestyle modification 
Key words: 
Compliance; hypertension; lifestyle modification; drug treatment 
xiv 
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CHAPTER 1 
INTRODUCTION 
1.1 Introduction 
Compliance to treatment is one of the most important factors in controlling high blood pressure 
and preventing and reducing cardiovascular diseases. Many factors affect compliance to drug 
treatment and lifestyle modification. 
This quantitative, descriptive, co- relational study focuses on identifying and explaining factors 
associated with compliance to anti-hypertension drug treatment and life style modifications 
among diagnosed hypertensive patients attending UNRWA, Governments, and NGOs primary 
health care clinics in the Bethlehem district. This chapter outlines the research problem, research 
justifications, aim and objectives of the research, research questions, study limitations, 
definitions of the key concepts, description of study setting and the conclusion of the chapter. 
1.2 Background  
Hypertension is one of the chronic non-communicable diseases (NCD). Hypertension is known 
as silent killer because it’s often asymptomatic. Hypertension is divided into essential 
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hypertension in which case no clear cause is found, and secondary hypertension which is 
attributed to causes such as renal or adrenal disease and various other reasons. 
40% of adults aged 25 and over had raised blood pressure in 2008, 17.3 million People died from 
cardiovascular diseases in 2008. Hypertension leads to nine million deaths every year, half of all 
deaths due to heart disease and stroke. High blood pressure is responsible for 13% of deaths 
globally in 2009. 80% of NCD deaths occur in low- and middle-income countries, and one in 
three adults has high blood pressure (Cardiovascular diseases (cvds), 2013). 
Any delay in detection and management of hypertension leads to damage to body organs and 
many complications. Hypertension is one of the important and major public health issues in 
Palestine and internationally. Hypertension is estimated to cause 7.1 million premature deaths 
and constitutes (Cardiovascular diseases, 2013). 
Incidence rates of hypertension range between 3% and 18%, depending on the age, gender, 
ethnicity, and body size of the population studied (Cardiovascular diseases, 2013). 
Morbidity, mortality and disability attributed to chronic, non-communicable diseases caused 
60% of all deaths. This percentage increased to 79% in developing countries, and made up 47% 
of the global disease burden in 2001. These percentages are expected to rise to 73% of the global 
deaths and 60% of the global disease burden by 2020 (Cardiovascular diseases, 2013). 
Failure of disease prevention, diagnosis and management of common preventable biological risk 
factors such as high blood pressure, high levels of cholesterol, obesity and related behavioral 
risks such as unhealthy diets, physical inactivity and tobacco use lead to four major conditions: 
cardiovascular disease, cancers, chronic obstructive pulmonary disease and type 2 diabetes 
(Global status report, 2010). 
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1.3 Research problem 
Hypertension or high blood pressure is a serious disease and causes many complications. It 
increases the risk of overall cardiovascular disease two to three fold and the risk of ischemic 
heart disease three to four fold (Sabaté, 2003). 
The incidence of stroke is nearly eight fold in hypertension patients, three- fold in patients at 
borderline, and forty percent of myocardial infraction or stroke is attributed to hypertension 
(Sabaté, 2003). 
Controlling high blood pressure prevents those complications and reduces the risk of heart 
diseases as well as reduces the direct and indirect economic burden of those complications. 
One of the main factors affecting blood pressure control is compliance to drug treatment and life 
style modifications which will be studied in this research. 
1.4 Justification 
Patients with chronic cases of hypertension need special care and management. Noncompliance 
to drug treatment and modifications in lifestyle are main problems of managing this disease and 
the main cause of uncontrolled hypertension. It’s very important to study the factors affecting 
compliance to treatment in order to improve the overall hypertensive patient’s health. Therefore, 
mismanagement of this disease leads to serious problems and complications for the patients, so 
it’s worth studying the factors that affect the compliance of the hypertensive patients to their 
treatment (of both medication and lifestyle modification). 
Through reading about this topic, there is a lack of published researches found about the 
compliance of hypertension patients among Palestinians. 
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1.5 Aim of study 
The aim of the study is to determine the factors affecting compliance to anti- hypertensive drug 
treatment and recommended lifestyle modifications among hypertensive Palestinian patients in 
the Bethlehem district. 
1.6 Study objectives 
1- To assess the compliance of the hypertension patients of UNRWA, Governments and NGOs 
to their hypertension treatment (drug treatment and lifestyle modifications). 
2- To assess the relationship between compliance to treatment of both the lifestyle modification 
and anti-hypertensive drug treatment variety and the following factors: socio-demographic 
factors (age, gender, marital status, educational status, work status, household income) and 
physiological factors (weight status, duration of illness). 
3-To assess the relationship between treatment compliance and the perception of severity;   
perception of risk; perception of benefits; perception of barriers; internal factors; health care 
provider factors. 
4- To assess the predictor variables for treatment compliance. 
1.7 Research question 
1-How compliant are the respondents with their hypertension drug treatment? 
2- How compliant are the respondents with their lifestyle modifications? 
3- What is the relationship between the treatment compliance and the socio-demographic 
factors? 
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4-What is the relationship between treatment compliance and the perception of severity; 
perception of risk; perception of benefits; perception of barriers; internal factors; health care 
provider factors; cues to action? 
5-Which of the following variables are predictor variables for treatment compliance: socio-
demographic variables; perception of severity; perception of risk; perception of benefits; 
perception of barriers; internal factors; health care provider factors; and cues to action. 
1.8 Study limitations 
1-The sample size is small because of the limited time of the study. 
2-Some of the patients who don’t come regularly to the clinic may not be included in the study 
even though those patients are very important to the study because they are not compliant with 
their treatment. 
3-The sample is not representative of all of the population because it is small and has been done 
in only in the Bethlehem district. 
1.9 Operational Definitions 
1.9.1: Blood pressure: Blood pressure is the force of blood pushing against the walls of arteries 
as it flows through them. Arteries are the blood vessels that carry oxygenated blood from the 
heart to the body's tissues. 
1.9.2: Drug treatment: A drug is a medicine or other substance which has a physiological effect 
when ingested or otherwise introduced into the body (Drug, 2013). Treatment is defined as 
“medical care for an illness or injury” (Treatment, 2013). In this study, drug treatment is defined 
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as the use of an approved pharmacologically active medicinal substance for the purpose of 
controlling hypertension. 
1.9.3: Compliance and adherence: WHO defines adherence as the extent to which a person’s 
behaviour, taking medication, following a diet, and/or executing lifestyle changes, corresponds 
with agreed recommendations from a health care provider (Sabaté, 2003). 
Compliance is the extent to which a person’s behaviour, in terms of keeping appointments, 
taking medications, and lifestyle changes, coincides with medical advice("Management of 
patient," 1982). 
 J. Urquhart at the European heart of hypertension defined compliance as “the extent to 
correspondence” which the patient's actual history of drug administration corresponds to the 
prescribed regimen. For the purpose of this study, compliance and adherence are used 
interchangeably (Urquhart, 1996). 
1.9.4: Compliance with prescribed anti-hypertensive drug treatment: 
Compliance with prescribed anti-hypertensive drugs was measured with compliance to 
Medication Regimen Instrument developed specifically for this study. The instrument contained 
14 closed-ended items on a four point Likert type scale. The mean score for the 14 items was 
calculated. A mean score of 3 was designated as the cut-off point. Respondents with a score 
below 3 were categorized as non-compliant while respondents with a score of 3 and above were 
categorized as compliant with the medication regimen. 
1.9.5: Compliance with life style modifications 
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 Compliance with lifestyle modifications aimed at lowering blood pressure includes regular 
exercise (at least 30 minutes three times per week), eating salt and fat free diets, cessation of 
smoking, and a reduction in the daily alcohol consumption to less than 20g of ethanol for men 
and less than 10g of ethanol for women. Compliance with lifestyle modifications were measured 
with compliance to Lifestyle Modification Instrument developed specifically for this study. The 
instrument contained 11 closed-ended items on a four point Likert type scale. The mean score for 
the 11 items was calculated. A mean score of 3 was designated as the cut-off point. The 
respondents with a score below 3 were categorized as non-compliant while respondents with a 
score of 3 and above were categorized as compliant with the lifestyle modification regimen 
1.9.6: Hypertension:  
Hypertension is high blood pressure. For the purpose of this study Hypertension is defined as 
systolic blood pressure (SBP) of 140 mm Hg or greater, diastolic blood pressure (DBP) of 90 
mm Hg or greater or taking antihypertensive medication(WHO, 2007) 
1.9.7: Lifestyle factors:  those attitudes, habits and behaviours of hypertension patients that 
influence the development and course of the disease 
1.9.8: Modification: a change (adjustment) in lifestyle, namely attitudes, habits and behaviours 
necessary for controlling hypertension. 
1.9.9: Patient: a person diagnosed with hypertension and receiving medical treatment 
1.9.10:Overweight and obesity: abnormal or excessive fat accumulation that presents a risk to 
health.  
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1.9.11:Body mass index (BMI): a simple index of weight-for-height that is commonly used to 
classify underweight, overweight and obesity in adults. It is defined as the weight in kilograms 
divided by the square of the height in meters (kg/m2). A person with a BMI of 25 or more is 
considered by WHO to be overweight while obesity is defined as having a BMI of 30 or more. 
Overweight and obesity are potent risk factors for cardiovascular diseases and type 2-diabetes 
and are major contributors to premature deaths (WHO, 2007). 
1.9.12: Physical activity: any bodily movement produced by skeletal muscles that require 
energy expenditure. Physical inactivity (lack of physical activity) has been identified as the 
fourth leading risk factor for global mortality (6% of deaths globally). Moreover, physical 
inactivity is estimated to be the main cause for approximately 21–25% of breast and colon 
cancers, 27% of diabetes and approximately 30% of ischemic heart disease burden. (WHO, 
2007) 
1.10 Summary 
This thesis consists of six chapters. In the first chapter, I discussed the aim of this study, specific 
objectives, research questions, problem statement, justification and limitations of the study. The 
next chapter presents the literature review of previous studies nationally and globally. In the third 
chapter, theoretical and conceptual frame work is discussed while in chapter four the study 
methodology, study setting, study population, study design, data collection tool, data analysis 
and ethical considerations are presented. In chapter five, study findings are presented in tables 
and figures while in the last chapter, chapter six, the results and finding are discussed, and 
recommendations and the conclusion of the study are presented. 
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Chapter 2 
Literature review 
2.1 Introduction 
In this chapter, the researcher focuses on the definition of hypertension, types, prevalence, 
causes, complications, and treatment of hypertension. In the second part of this chapter, 
compliance of drug treatment and lifestyle modifications is discussed; factors affecting 
compliance to hypertension treatment also are discussed in this chapter. 
2.2 Definition of Hypertension 
2.2.1: What is raised blood pressure (hypertension)? 
Hypertension, high or raised blood pressure, is a condition in which the blood vessels have 
persistently raised pressure. Blood is carried from the heart to all parts of the body in the vessels. 
Each time the heart beats, it pumps blood into the vessels. Blood pressure is created by the force 
of blood pushing against the walls of blood vessels, arteries, as it is pumped by the heart. The 
higher the pressure the harder the heart has to pump. 
Normal adult blood pressure is defined as a blood pressure of 120 mm Hg1 when the heart beats 
(systolic) and a blood pressure of 80 mm Hg when the heart relaxes (diastolic). When systolic 
blood pressure is equal to or above 140 mm Hg and/or a diastolic blood pressure equal to or 
above 90 mm Hg the blood pressure is considered to be raised or high. 
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Hypertension is defined as systolic blood pressure (SBP) of 140 mm Hg or greater, diastolic 
blood pressure (DBP) of 90 mm Hg or greater or taking antihypertensive medication (The sixth 
report, 1997). The seventh report of the Joint National Committee made some changes in the 
classifications of hypertension as in the following (table 2.1). 
 
Table 2.1: classifications of blood pressure for adults aged ≥ 18years   
 
 
 
The European classification of blood pressure is provided by the European society of 
hypertension and the society of Cardiology as shown in (Table 2.2). 
 
Table 2.2: classification of blood pressure for adults 
 
 
 
 
 
 
 
Blood pressure 
classification 
Systolic blood 
pressure 
Diastolic blood 
pressure 
Normal < 120  and <80 
Pre-hypertension 120-139 or 80-90 
Stage 1 hypertension 140-159 or 90-99 
Stage 2 hypertension >160 or ≥ 100 
Category Systolic blood 
pressure(mmHg) 
Diastolic blood 
(pressure(mmHg) 
Optimal <120 <80 
Normal 120-129 80-84 
High normal 130-139 85-89 
Grade1 hypertension 140-159 90-99 
Grade2 hypertension 160-179 100-109 
Grade3 hypertension ≥180 ≥110 
Isolated systolic 
hypertension 
≥140 <90 
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2.2.2. Causes of hypertension: 
Hypertension is divided into two types. Primary or essential hypertension results from 
deregulation of normal homeostatic control of blood pressure mechanism in the absence of 
known causes and represents 95% of all cases of hypertension. 
Secondary hypertension results from a disorder of the body such as renal dysfunction or 
endocrine problems and represents <5%, both systolic and diastolic raised. 
Systolic hypertension results from increased cardiac output, rigidity of aorta, and iatrogenic 
hypertension. 
2.2.3 Prevalence of hypertension: 
The overall prevalence of hypertension was 27.6%, with a higher percentage among men (29.2 
vs. 26.4%) among Palestinian adult aged 25 years and over.  Hypertension increased with age in 
both men and women, prevalence of hypertension was slightly higher in urban than in rural 
areas(Khdour, Shaeen, Jarab& Al-shahed, 2013). In Gaza strip, the prevalence rate of 
hypertension was 17% (Abed & Abu-Haddaf, 2013). 
The prevalence of hypertension in the United States according to Census Bureau in 2007-2008 
was 28-30 % in 18 year olds and older.  Obesity was the major cause of this high percentage. In 
Canada, the percentage was 28% and in the European countries the percentage increased to 44 % 
(Sung, Burt, Louis & Carroll, 2012). 
According to the UNRWA annual health report in 2011, the prevalence of diagnosed 
hypertension among the served population 40 years of age or older was 17.5 % in all UNRWA 
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fields which depicts an increase compared to 2010 when percentage was a slightly lower 17.3%. 
The highest rate was reported in the Gaza Strip where the percentage went as high as 19.2% 
followed by Lebanon with a percentage of 19.0%, Syria at 16.9 %, the West Bank at 17.3%,and 
finally Jordan at 16.3%. The above data is based on the refugees who attended the UNRWA 
clinics (The annual report," 2012). 
2.2.4 Complication of hypertension: 
There are many complications developed because of hypertension involving cardiovascular, 
cerebrovascular, renal and ocular systems if the disease isn't treated in the proper way. 
Cardiovascular disease 
High blood pressure can cause many different diseases of the heart and blood vessels. These 
diseases are medically known as cardiovascular diseases including: Stroke, which occurs when 
the blood supply to part of the brain is cut off, heart attack, which happens when the supply of 
blood to the heart is suddenly blocked, embolism, which occurs when a blood clot or air bubble 
blocks the flow of blood in vessel, and aneurism, which occurs when a blood vessel wall bursts 
causing internal bleeding(Cardiovascular diseases, 2013). 
Complications affecting the heart 
Hypertensive heart disease is the result of structural and functional adaptations leading to left 
ventricular hypertrophy, diastolic dysfunction, and abnormalities of blood flow due to 
atherosclerotic coronary artery disease and micro-vascular disease and cardiac arrhythmias. 
Individuals with left ventricular hypertrophy are at risk for stroke and sudden 
death(Cardiovascular diseases, 2013). 
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Complications affecting the brain 
Hypertension is an important risk factor for brain infraction and haemorrhage. Approximately 
85% of strokes are due to infraction, and the remainder are due to haemorrhage. The incidences 
of stroke rise progressively with increasing blood pressure levels, particularly systolic blood 
pressure in individuals> 65 years. Treatment of hypertension decreases the incidences of both 
ischemic and haemorrhage strokes (Cardiovascular diseases, 2013). 
Complications affecting the eye 
Hypertension retinopathy is a condition characterized by a spectrum of retinal signs in people 
with elevated blood pressure. When blood pressure is elevated, circulation undergoes serious 
pathophysiological changes. Clinically, the vasoconstrictive stage is the initial stage of 
narrowing retinal arterioles followed by the sclerotic stage of more severe and more narrowing of 
the arterial and venular junctions. This is followed by the exudative stage in which there is an 
exudation of blood and lipids and retinal ischemia 
Complication affecting the kidneys:] 
Hypertension is a risk factor for renal injury;renal risk is more closely related to systolic than to 
diastolic pressure.  High blood pressure can also damage the small blood vessels in the kidneys 
and stop them from working properly. This can cause a number of symptoms, including: 
tiredness, swollen ankles due to water retention, shortness of breath, blood in urine and itching 
skin. 
2.2.5 Treatment of hypertension: 
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All individuals with blood pressure at or above 160/100 mm Hg, or a lesser degree of raised 
blood pressure with target organ damage should have drug treatment and specific lifestyle 
modification advice to lower their blood pressure and consequently lower their risk of 
cardiovascular disease.     
Individuals with persistent blood pressure ≥ 130/80 should be given one of the following drugs 
to reduce blood pressure and lower the risk of cardiovascular disease: thiazide like-diuretic, ACE 
inhibitor, calcium channel blocker, and beta-blocker. This is recommended the first line therapy. 
Individuals with persistent blood pressure ≥ 140/90 mmHg who are unable to lower blood 
pressure through lifestyle strategies with professional assistance within 4-6 months should be 
given one of the following drugs to reduce blood pressure and lower the risk of cardiovascular 
disease: thiazide like diuretic, ACE inhibitor, calcium channel blocker, and beta-blocker. 
Individuals with persistent blood pressure ≥ 140/90 mmHg should continue lifestyle strategies to 
lower blood pressure and reduce cardiovascular risk and be reassessed annually depending on 
clinical bases and resource availability. 
2.3 Compliance   
When a patient adheres to a prescribed medical regimen, he is said to be compliant. Webster's 
dictionary defines compliance as "acquiescence to a wish, request, or demand" or "a disposition 
or tendency to yield to the will of others." Thus, compliant behavior may be defined as a class of 
behaviors resulting from a specific set of cues and consequences. Some of these cues may be 
related to a request by a physical therapist while others relate to physical symptoms, time, and 
occasion e.g., patient takes prescribed medication or follows prescribed diet. The consequences 
may be the relief of symptoms such as lessened angina symptoms, a sense of well-being, 
personal satisfaction such as achieving weight loss or fitness goals, or avoidance of disease 
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resulting in a lower morbidity or mortality rate. Although behaviors may look alike, a cardiac 
patient who exercises is termed compliant if the type, frequency, intensity, and duration criteria 
are appropriate for the level of recovery and physical capabilities of that patient. Running five 
miles two weeks after a massive anterior myocardial infarction is not compliant behavior. 
Training at 80% to 90% of the low level exercise test heart rate in an ECG-monitored 
rehabilitation program would be compliant behavior for this patient. Thus, compliance reflects an 
action in the present that is chosen to benefit the future (Randolph, 1985). 
J. Urquhart at the European heart of hypertension defined compliance as “the extent to 
correspondence” which the patient's actual history of drug administration corresponds to the 
prescribed regimen(Urquhart, 1996). 
This definition includes both quantity and timing of doses. Thus, this definition puts the 
measurementof compliance into terms that allow a pharmacometric interpretation (Urquhart, 
1996). 
WHO defines adherence as the extent to which a person’s behaviour, taking medication, 
following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations 
from a health care provider. (Sabaté, 2003) Beyond that definition, adherence can be understood 
in three categories 
1. Initiation: when the patient takes the first dose of a prescribed medication 
2. Execution:  the extent to which a patient’s actual dosing corresponds to the prescribed 
dosing regimen from initiation until the last dose 
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3. Discontinuation:when the patient stops taking the prescribed medication for whatever 
reason(s)(Sabaté, 2003). 
Researchers have used the terms compliance and persistence amongst others in the past, but the 
term adherence is now widely accepted (Ascertaining barriers for, 2012). 
2.3.1 Factors affecting compliance: 
According to WHO publications about adherence to long term therapy, adherence is a 
multidimensional phenomenon determined by five dimensions: social / economic factors, health 
system factors, therapy-related factors, condition- related factors, and patient-related factors. The 
published literature suggests that people are more accurate in reporting non-adherence when 
asked simple questions about recent behaviour(Sabaté, 2003). 
Social and economic factors 
Low socioeconomic status has been found as an important and independent predictor of 
adherence. In developing countries, there most important include the demand to their initial 
requirements such as the needs of children. Poor socioeconomic status, poverty, illiteracy, low 
level of education, unemployment, lack of effective social support networks, unstable living 
conditions, proximity to treatment centre,  high cost of transport, high cost of medication, 
changing environmental situations, culture and beliefs about illness and treatment, and family 
dysfunction are reported to have significant effect on compliance (Sabaté, 2003). 
Gender   
A study done in Ethiopia (2012) found that there was a significant association between sex and 
compliance level; men were found to be less adherentthan women. This finding is similar to the 
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finding of a study done in India where men had almost threefold increase in risk of non-
adherence compared to women(DessieAmbaw, AsresAlemie, Solomon &BirhanuMengesha, 
2012). 
In Finland, a study done about compliance found that 14% of the males and 13% females were 
reported non-compliance with anti-hypertensive medication, the prevalence rates of reported 
non-compliance for men were as follows 17% (55 years), 18% (55-64years), 9% (65-74years) 
and 13% (75years). The respective prevalence rates for women were 15%, 17%, 13% and 19% 
((Jokisalo, Kumpusalo, Enlund, Halonen&Takala, 2002). 
Another study found that compliance appears to be similar among men and 
women(O’Hanrahan& O'Malley, 1981). 
Nationally, a study about the rate of compliance among patients with Diabetes and Hypertension 
in North Palestine was done by Waleed Sweileh and others from Al-Najah University.The results 
show that there is no significant relationship between gender and the rate of compliance based on 
the contingency test results (Sweileh, Aker & Hamooz, 2005). 
In a study done about compliance with anti-hypertensive treatment among the patients attending 
the PHC clinics in Hebron, Mohammad Wridat from Al-Quds University measures compliance 
as well. In his study, males were non-compliant 1.591 times more than females(wridat, 2012). 
 A study was done by Sa’ed H. Zyoyd from Al Najah University and others about the health-
related quality of life associated with treatment adherence in patients with hypertension. A cross-
sectional study design was used to address the research goals, and the study was conducted in the 
outpatients' clinics at Al-Makhfyah Primary Health Care Clinic and at Alwatani Hospital in 
Nablus, Palestine.A convenience sample of 410 hypertensive outpatients was identified between 
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July and October 2012. In this study, the female gender was associated with a higher Morisky 
eight-item Medication Adherence Scale (MMAS) score ( Zyoud, Al-Jabi , Waleed M, Aysha H, 
Hanan M , Hayat A , Mohammad A &Rahmat , 2013). 
Age 
Many elderly patients have chronic diseases and require complex long–term therapy treatment, 
so compliance to treatment is essential to improve the wellness of those patients, the failure to 
adhere to the recommended treatment has been found to increase the likelihood of treatment 
failure and unnecessary complications like disability and early death. Poor adherence or 
compliance affects all age groups, and the prevalence of cognitive and functional impairments in 
elderly patients increases their risk of poor adherence (Sabaté, 2003). 
According to (WHO 2003a:29) elderly patients tend to have poor compliance because of 
memory loss and reduction in functional capabilities such as eyesight loss and the decreased  
ability of the hands to do activities such as bottle opening. 
Sa’ed H. Zyoyd's study revealed that patients over the age of 68 years had a lower median 
MMAS score than those less than 68 years (Zyoud, Al-Jabi , Waleed M, Aysha H, Hanan M , 
Hayat A , Mohammad A &Rahmat , 2013). 
Education 
Socioeconomic factors such as illiteracy are risk factors of poor adherence (Sabaté, 2003)another 
study signifies that non-compliance was less prevalent among the more highly educated than 
among the less educated ((Jokisalo, Kumpusalo, Enlund, Halonen&Takala, 2002). 
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In Japan, a study done about compliance showed thecompliance rate was significantly higher in 
patients who graduated from university or college than in patients who did not (Mizuno, 
Fujimoto, Uesugi, Danno, Maeda, Kanno, Matsumura & Fujimoto, 2002). 
Nationally, Wridate's thesis indicates that education didn’t affect compliance with treatment 
regimen. (Wridat, 2012)Sa’ed H. Zyoyd's study found that the MMAS score increased as the 
educational level of patients increased. (Zyoud, Al-Jabi , Waleed M, Aysha H, Hanan M , Hayat 
A , Mohammad A &Rahmat , 2013). 
Employment 
A socioeconomic factor such as unemployment is a risk factor of poor adherence (Sabaté, 2003). 
The compliance rate was studied in a research paper about the influence of living style on taking 
anti-hypertensive agents in patients. The compliance rate for patients with essential hypertension 
was significantly lower in patients with an occupation than in those who were unemployed 
(Mizuno, Fujimoto, Uesugi, Danno, Maeda, Kanno, Matsumura & Fujimoto, 2008). 
 In patients with an occupation, the compliance rate was significantly lower in patients engaged 
in physical labour than in patients engaged in office work and was significantly lower in patients 
working for a shifted time during the day than in patients working for a fixed time (Mizuno, 
Fujimoto, Uesugi, Danno, Maeda, Kanno, Matsumura & Fujimoto, 2008). 
Marital status 
The World Health Organization issued a report about adherence to therapy of long term diseases; 
one of these diseases was hypertension. The report reviewed many studies and summarizes the 
factors affecting adherence. The report showed that two important factors contributing to poor 
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adherence were the silent nature of the disease (asymptomatic) and the longevity of the disease. 
Other factors or determinants that may be related to compliance are: demographic factors such as 
age, gender, and education, the patient’s understanding and perception of hypertension; the 
relationships between patients and health care professionals; health systems influences and 
complex antihypertensive drug regimens(Sabaté, 2003). 
 Nationally, Wridate's thesis indicates that marital status didn’t affect compliance with a 
treatment regimen(wridat, 2012). 
Duration of illness 
In Japan, a study done about compliance showed the compliance rate was not different between 
patients with duration of ≥ 10 years and those with that of <10 years. (Mizuno,Fujimoto, Uesugi, 
Danno, Maeda, Kanno, Matsumura & Fujimoto, 2008). 
 A study done in Turkey found that the patients suffering from hypertension for 11 years or more 
generally took their medicine as prescribed, but the difference between groups on this factor was 
insignificant(Karakurt&Kasikci, 2012).In Finland, a study about compliance of treatment with 
hypertensive drugs showed that the duration of illness (<5 years, 5-9, ≥ 10 years) was non-
significant (Jokisalo, Kumpusalo, Enlund, Halonen&Takala, 2002). 
Nationally, Wridate's thesis indicates that the patients with 10-20 years duration of illness were 
less compliant than those with <10 years (wridat, 2012). 
Number of medication 
In a review of WHO studies, mono-therapies and fewer changes in antihypertensive medications 
(less treatment turbulence) have all been associated with better adherence (Sabaté, 2003). 
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In the Japanese study, the compliance rate was significantly lower in patients taking a twice or 
more a day regimen than in patients taking medications once a day(Mizuno, Fujimoto, Uesugi, 
Danno, Maeda, Kanno, Matsumura & Fujimoto, 2008). 
In Finland, the study showed non-compliance was less prevalent in the group with two drugs 
than in the one with one drug(Jokisalo, Kumpusalo, Enlund, Halonen&Takala, 2002). 
Wridat's thesis indicates that the patients who took two drugs were less compliant than those who 
were taking only one drug, and those who were taking three drugs were less compliant than those 
who were taking only one drug(wridat, 2012). 
Sa’ed H. Zyoyd's study found that the MMAS score decreased as the total number of 
medications increased (Zyoud, Al-Jabi, Waleed M, Aysha H, Hanan M, Hayat A, Mohammad A 
&Rahmat, 2013). 
Doses of medication 
The WHO report indicates that simple dosing schedules have positive effects on adherence, and 
fewer daily doses of antihypertensive therapies have all been associated with better adherence  
( Sabaté, 2003). 
In the Japanese stud, compliance rates were significantly lower in patients taking a twice or more 
a day regimen than in patients taking medications only once a day (Mizuno, Fujimoto, Uesugi, 
Danno, Maeda, Kanno, Matsumura & Fujimoto, 2008). 
In A Hashmi study, an inverse relationship was observed between adherence and number of pills 
prescribed. Patients on mono-therapy had a mean adherence of 79% compared to 90% for those 
on three drugs or more. A meta-analysis of eight studies reports that the average adherence for 
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once-daily dosing was significantly higher than for multiple daily dosing, 91.4% vs 83.2% 
respectively (Hashmi, Afridi, Abbas &Sajwani, 2007). 
Daily dosing in Wridate's study was not significant and didn’t affect the compliance of the 
patients with their treatment regimen (wridat, 2012). 
Sa’ed H. Zyoyd's study revealed the low significance of MMAS score in participants receiving 
combination therapy as hypertension treatment(Zyoud, Al-Jabi , Waleed M, Aysha H, Hanan M , 
Hayat A , Mohammad A &Rahmat , 2013). 
Health care system related factors 
With regards to the WHO report, the factors related to health care provision  such as the lack of 
knowledge and training for health care providers on managing chronic diseases, inadequate 
relationships between health care provider and patient,  lack of knowledge, inadequate time for 
consultations, and lack of incentives and feedback on performance have negative effects on 
adherence for hypertension treatment while good relationships between patients and physicians 
have  positive effects on adherence to hypertension treatment ( Sabaté, 2003). 
A study was conducted in Finland to study the association of factors related to the health care 
system, and the patients self- reported about non-compliance with medication in primary health 
care. 88% of the patients reported having one or more perceived health care system-related 
problems ((Jokisalo, Kumpusalo, Enlund, Halonen&Takala, 2002). 
 The proportion of non-compliant patients increased significantly along with the increasing 
number of perceived health care system-related problems from 5% to 24% while the proportion 
of non-compliance in patient-related problems increased from 5% to 21%. Those with a high 
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level of perceived health-care related problems were almost four times more likely to be non-
compliant, and those with a high level of patient-related problems were two times more non-
compliant ((Jokisalo, Kumpusalo, Enlund, Halonen&Takala, 2002). 
Locally, Wridate's thesis displays that the patients number of visits for follow up and drug 
prescription was significantly tied with compliance; patients who visit their doctors every three 
months were 2.886 less compliant when compared to those who visited the doctor regularly 
every month(wridat, 2012). 
Therapy related factors: 
WHO reports indicate that mono-therapy with simple dosing schedules, less frequent doses, 
fewer changes in anti-hypertensive medications, and newer classes of drugs such as  angiotensin 
II antagonists, angiotensin converting enzyme inhibitors, and calcium channel blockers have 
positive effects on adherence to hypertension treatment while complex treatment regimen, 
duration of treatment, low drug tolerability, and adverse effects of treatment have negative 
effects on adherence to hypertension treatment (Sabaté, 2003). 
In the Japanese study, the compliance rate was lower in patients taking two or more kinds of 
antihypertensive agents than patients taking a single kind, but it was not significant. Compliance 
rates were not different among kinds of anti-hypertensive agents. When patients were divided 
into three groups according to the level of satisfaction with the present treatment with 
antihypertensive agents,satisfied, dissatisfied, and neither, the compliance rate was lowest in 
patients with dissatisfaction and highest in patients with satisfaction (Mizuno, Fujimoto, Uesugi, 
Danno, Maeda, Kanno, Matsumura & Fujimoto, 2008). 
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Condition or disease related factors: 
WHO reports showed that understanding and perceptions about hypertension have positive 
effects on adherence to hypertension treatment(Sabaté, 2003). 
 In a study done about factors associated with adherence to anti-hypertensive treatment in 
Pakistan in 2007 by Hashmi and others, the adherence rates were calculated as "pills taken over a 
specific period of time, divided by pills prescribed for that specific period of time."  The study   
concludes that the overall level of awareness about hypertension and its treatment was very low, 
and a very small proportion of patients were aware of the risk factors for hypertension.  An even 
smaller proportion knew about the complications. Greater awareness was associated with higher 
adherence (Hashmi, Afridi, Abbas &Sajwani, 2007). 
Patients related factors: 
WHO reports showed that perception of the health risk related to the disease,  active participation 
in monitoring,  and participation in management of the disease all have positive effects on 
adherence to hypertension treatment.  On the other hand, inadequate knowledge and skill in 
managing the disease symptoms and treatment, no awareness of the costs and benefits of 
treatment, and non-acceptance of monitoring all have negative effects on adherence to 
hypertension treatment (Sabaté, 2003). 
A study conducted in Finland to assess the association of patient related problems with 
compliance revealed that 92% have patient-related problems. The proportion of non-compliance 
in patient-related problems increased from 5% to 21% comparedto those with a high level of 
perceived health-care related problems. 
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Locally, Wridate's thesis displays that the patient's perception of hypertension as a serious 
problem revealed an overall significant effect on the blood pressure treatment adherence. Those 
who answered that hypertension is sometimes or rarely a serious problem were less compliant 
than those who considered hypertension as always a serious condition(Sweileh, Aker & Hamooz, 
2005). 
The factors that affected HBM are the perception of susceptibility, perception of the severity of 
hypertension, perception of benefits, perception of barriers, modifying variables, self-efficacy, 
and cues to action. All of which will be fully discussed in chapter three in the conceptual frame 
work of the model. 
2.3.2 Measuring Compliance: 
In order to manage the patient’s compliance to the hypertension treatment, compliance should be 
measured accurately and effectively.The following methods could be used to measure 
compliance. 
Monitoring Attendance 
Monitoring attendance at appointments is critical because up to 50% of hypertensive patients 
drop out of care within 1 year of beginning.  Because many primary health care providers do not 
follow up appointments of the patient’s appointment attendance is not evidence of a patient's 
compliance. However, the studies show about one-third of patients who remain in care fail to 
follow the prescribed treatment (Haynes, 1982). 
Clinical Judgment 
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Clinical judgement is the most common method of assessing medication compliance. It’s 
attractive to clinicians and easily applied, but clinicians cannot reliably predict the compliance of 
their patients because they depend on subjective impressions in monitoring compliance (Haynes, 
1982). 
Patient Self-Reports 
Patients tend to overestimate the amount of medication they are taking. About half of non-
compliant patients will admit missing at least some medication, and the ease with which this 
information can be obtained makes it very valuable. It is one of the few ways that can distinguish 
between the pattern and the quantity of the medical quantity consumed(Haynes, 1982). 
Pill Counts 
Pill count's is a quantitative estimation of compliance over a period of time. It is reliable if it is 
done at the patient's home, but it is not practical.Pill counts give higher estimates of compliance 
than biological essays and lower compliance levels than patient self-reports (Haynes, 1982). 
Drug Level Measurement 
Drug level measurement can be useful for drugs that have a sufficiently long half-life; however, 
drug level assessments are not routinely available for anti-hypertensive drugs.(28) 
 Biological Effects Assessment 
The biological effects of drugs have not been found to correlate well with compliance(Haynes, 
1982). 
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Patient Reactivity 
Reactivity occurs   if patients become aware of the purpose of the assessment. In this case, they 
may change their compliance in a favourable direction which seems to be a clinically useful 
phenomenon (Haynes, 1982). 
2.4 Summary: 
In this chapter, hypertension and it's different definitions,, causes, treatment complications, 
prevalence of hypertension and its definitions were all discussed as well as the factors related to 
compliance with regards to HBM.  Social and economic factors such as gender, age, education, 
marital status, duration of illness, number of medication, doses of medication, health care system 
related factors, therapy related factors, Condition or disease related factors and patients related 
factors were all discussed as well.  
The factors that affected HBM were the perception of susceptibility, perception of the severity of 
hypertension, perception of benefits, perception of barriers, modifying variables, self-efficacy, 
Cues to action, and the  method of measuring compliance. 
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Chapter Three 
Conceptual Framework 
3.1  Introduction 
In this chapter, we will discuss the models related to explaining health behaviors such as 
compliance to treatment. We will focus on the health belief model, which is used in this study as 
a conceptual framework, its origin development, components and the ethical considerations 
related to compliance behavior. 
3.2 Theories of compliance 
Educational Model 
The basis of the educational model is that the patients lack sufficient knowledge of their illness 
and treatment, but the studies ("Management of patient," 1982) show that this is more suitable 
for short-term treatments, less than 2 weeks in duration, and, therefore, has very limited value for 
chronic disease regimens. 
Emotional Drive Model 
The Emotional Drive Model   is a mixture of the health belief and educational model. In order to 
achieve compliance, the patients receive information and knowledge about the illness 
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(educational model) and threat messages meant to arouse fear in the patient about the 
consequences of non-adherence to treatment. Most of the studies have shown that this model 
effects short-term compliance more than long-term compliance ("Management of patient," 
1982). 
Behavioral Learning Model 
The Behavioral Learning Model explains the compliance depending on the Operant 
("Management of patient," 1982) learning theory by Skinner which states that behavior is solely 
the result of environmental cues and rewards. First, this model holds that the individual's 
interpretation of the environment determines what is reinforcing and what is not. Second, it uses 
modeling to teach people how and when to respond without rewards for performing the response 
("Management of patient," 1982). 
Self-Regulation Model 
The Self-Regulation Model describes the role and method of an individual acting with health 
advice. 1) Extracting information from the environment. 
2) Generating a representation of the illness' danger to oneself. 
3) Planning and acting, that involves imagining response alternatives to deal with the problem 
and taking selected actions to achieve specific effects. 
4) Monitoring how one’s coping reactions affect the problem and oneself (Management of 
patient, 1982). 
Health Belief Model (motivational model) 
The Health Belief Model (Figure 3.1) is the most common “motivational model" of compliance. 
It holds that an individual's cooperation with health advice depends on the extent of the person's 
perception and susceptibility to the seriousness of the disease, treatment efficacy, and how to 
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3.3 History and origin of the Health Belief Model 
HBM was developed in the 1950s by social psychologists to explain the failure of the 
tuberculosis screening program in the United States. Beker modified this model in 1974 to 
predict participation in health detection and prevention programs (Samuel, Gangne&kasper, 
1994). 
The four main perceptions of the HBM are the perception of susceptibility (risk), perception of 
severity, perception of benefits, and perception of barriers. The model was modified in 1988 to 
include self-efficacy and cues to action. 
Bekers explains that for a patient to take an action to prevent a disease, that patient must believe 
that they are susceptible to a that specific disease, believe in the serious consequences of the 
disease, believe that the actions taken have benefit and believe that the barriers involved with 
making the change are not too great and can be successfully overcome(Samuel, Gangne&kasper, 
1994). 
3.3.1Components of the conceptual model: 
Health behaviors are influenced by a person’s desire to avoid illness or to get well and by their 
confidence that the recommended action will achieve this affect. The person’s perception 
influences their behaviors. This approach associates health behavior and demographic factors 
such as social class, ethnicity, sex, age. 
Description 
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In HBM, the likelihood that a person will follow a preventive behavior is influenced by their 
subjective weighing of the costs and benefits of the action. 
Perception of susceptibility 
A patient's perception of susceptibility refers to one’s subjective perception of the risk of 
contracting a condition (K. Janz& Marshall, 1984). 
 Individuals vary widely in their feelings of personal vulnerability to a condition such as 
hypertension or the complications of uncontrolled hypertension such as heart attack or kidney 
failure, ocular complications or stroke. Since hypertension is asymptomatic disease, patients 
must believe that they are susceptible to develop the disease and its complications. This 
perception depends on the knowledge of the nature of the disease and the risk associated with 
compliance to treatment. In regards to the HBM, the patients who feel susceptible to 
hypertension and its complications would likely to be more compliant to their treatment than 
those who do not hold this belief. 
Perception of severity of hypertension: 
The perception of severity of hypertension is the patient's feelings concerning the seriousness of 
contracting an illness or of leaving it untreated. It also varies between person to person.  This 
dimension includes both medical consequences (e.g., death, disability, and pain) and social 
consequences (e.g., effects of disease on work, family, life, and social relations)(K. Janz& 
Marshall, 1984). According to the HBM, persons who perceive hypertension to be a serious 
disease would be more compliant with their medication treatment and lifestyle modifications 
than those who don’t hold this perception. 
33 
 
The individual perceptions of the HBM are the perception of severity and the perception of 
susceptibility which combined to make the perception of threat, or “the anticipation of harm that 
is based on the cognitive appraisal of an event or cue that is capable of eliciting the individual’s 
stress response.This perception is a cognitive component and depends on information. It doesn’t 
determine how the person will act but creates pressure to act and is influenced by the balance 
between the perceived efficacy and the cost of alternative course of action. Persons who believe 
that they are not susceptible to hypertension or deny the existence of the disease may not see the 
need to ingest their medications as prescribed or change their lifestyle. 
Perception of benefits  
Perception of benefits is the person’s opinion of the value or usefulness of a new behavior in 
decreasing the risk value of developing a disease (Samuel, Gangne&kasper, 1994). 
Assessments of perceived benefits associated with the behavior have been reported to increase 
the explanatory power of the model. Rosenstock said that perception of threat may encourage the 
persons to take action depending on the benefits of this action (effectiveness of the behavior in 
reducing the threat of illness (Samuel, Gangne&kasper, 1994). 
Perception of barriers 
Perception of barriers refers to the obstacles or negative outcomes of treatment such as expense, 
pain, or inconvenience (Samuel, Gangne&kasper, 1994). In order to adopt a new behavior the 
patient has to overcome those obstacles or barriers and he has to believe that benefits of the new 
behavior outweigh the consequences of the old behavior. Perception of barriers is the most 
significant factor in determining behavior change (Samuel, Gangne&kasper, 1994). 
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Modifying variables 
Self-efficacy 
Self- efficacy is the belief in one’s own ability to do something; in general, no one tries to do 
something new unless he or she believes that the new behavior is useful (perceived benefits), and 
also that he or she is capable of doing the new behavior(perceived barriers(Samuel, 
Gangne&kasper, 1994). 
Cues to action 
Cues to action are events, people, or things that move people to change their behavior such as an 
illness of a family member, media reports, mass media campaigns, advice from others, reminder 
postcards from health provider, or health warning labels on products (Samuel, Gangne & kasper, 
1994). 
People must feel threatened  by their current behavioral patterns ( peceived susebtibilty and 
severity) and believe that change of a specific kind will be beneficial byresulting in a valued 
outcome at an acceptable cost. They must also feel that they themselves  are competent  ( self 
efficacy) to implement that change(Samuel, Gangne & kasper, 1994). 
Modifying factors influence individual’s perceptions and compliance behavior. Various 
modifying factors include socio-demographic, socio-psychological and structural factors. All of 
which influence health behavior. Another modifying factors the social support of the family and 
friends that help patients manage their treatments, both social learning and self-regulation 
theories point to a number of complex ways that social support can enhance compliance 
(Haynes, 1982). 
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Clinician –Patient Relationship 
Research on clinician-patient relationships are classified into four categories. The first category 
uses educational techniques to inform patients about their prescribed treatment. Studies show 
that greater provider explicitness regarding needed patient behaviors is associated with better 
patient follow-through (Haynes, 1982).  
The second category of study addresses the extent to which clinicians and patients share the 
same expectations about their interactions and the effect of this on subsequent patient 
compliance (Haynes, 1982). 
The third category includes investigations into patients' acceptance of responsibility. Compliance 
is better among patients who feel that they are actively involved in their own care (Haynes, 
1982). 
The last category concerns the affective tone of the patient-clinician encounter. Studies observed 
directly support the concept that approachability and friendliness of the clinician to the patient 
are positively correlated with compliance (Haynes, 1982). 
3.3.2 Ethical Concerns in Applying Compliance Strategies: 
While attempting to improve compliance in the medical practice, the following ethical issues 
should be considered. First, the diagnosis must be correct. Secondly, the efficacy of therapy 
should be examined. Subsequently, the patient must be an informed and willing partner in any 
attempts to alter his compliance behavior. Finally, the strategy employed to improve compliance 
must also be advantageous (Haynes, 1982). 
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Chapter four  
Methodology 
4.1Introduction 
This study aims to assess the factors affecting compliance to ant hypertension drug treatment and 
lifestyle modifications among patients attending primary health care clinics in the Bethlehem 
district. In this chapter, the research methodology including the study design, data collection 
tools, and data analysis will be presented. . 
4.2 Study design  
This study is quantitative (cross sectional) which is easily applicable and cost effective. This 
design was chosen to meet the objectives of the study to determine the factors that affect the 
compliance to hypertension treatment.  It is a technique that enables the researcher to collect 
numerical data and answer the research question. 
4.3 Study population 
The study population is composed of the hypertension patients ages eighteen and over who are 
registered as hypertension patients and who have received curative and preventive health care 
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services for more than one year at Dehaishe UNRWA clinic, Bethlehem governmental clinic, 
and NGO's mobile clinic.  
Eligibility 
Members of the population who are included in the study 
• diagnosed with hypertension. 
• placed on treatment for at least one year prior to data collection. 
• aged between 18 to 80 years. 
Excluded Patients 
• were too sick to be interviewed. 
• could not give informed consent. 
      • couldn’t reach the clinic because of serious diseases. 
      • Hypertensive patients with diabetes mellitus. 
      • were mentally unstable. 
4.5 Sampling method 
Systematic random sampling was used to select the participants from the three clinics. It’s a way 
to select a probability – based sample from a directory or list. From the list, the researcher 
selected the starting point (kth) randomly and systematically picked every 4th subject until 300 
subjects were gathered from all clinics. 
Sampling interval (SI) = population list size (N) divided by a predetermined sample size (n). 
K= 1100/300=3.6 = 4 
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The clinics which were included in the study include the following: Dehaishe clinic from 
UNRWA, Bethlehem health centre from governmental sector, and Al-Rbayah mobile clinic from 
the NGO's Medical Relief Society. 
The three clinics were selected purposefully because the researcher believed them to be typical 
of the population he wished to study. Dehaishe clinic’s hypertensive patients represent 439 
subjects (165male and 274 female), so it was easy to gather the exact number for the selected 
sample size. 
Bethlehem government clinic contained nearly 300 patients. The number of patients  who visited 
the Bethlehem governmental clinic before the separation of this clinic into three major clinics, 
BeitSahour, Beit Jala, Al-Obadyeh,  on February 2012 were 737 visitors  while the number 
patients of who visited Bethlehem chronic clinic between January 2012-May2012 was  246 
visitors. However, the researcher selected a sample of 100 because the patients did not have a 
serial number and the exact number of the patients was not known. 
 At the NGO's mobile clinic, the researcher selected 100 patients. The total number of 
hypertensive patients was not known, so it is difficult to calculate the exact number of the sample 
size for the research at the NGO's mobile clinic. 
4.6 Sample size  
A representative systematic sample was used.  The sample was calculated according to the 
known formula n= N/1+N (e) 2 after revising it with a statistical specialist, and after calculating 
the exact number of the patients at the specific clinics. 
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4.7 Study tool 
A pre- used and standardized questionnaire was used to collect the data from the studying 
sample. The tool (prepared questionnaire) was borrowed from a South Africanstudy which had 
the same objectives The South African study was conducted at South African University as a 
master thesis(Akpan Edo, T, 2009). The tool was adapted and translated before being reviewed 
by three PhD holders from the school of public health at Al-Quds University and two doctors 
from the UNRWA who were responsible for the non-communicable disease programs and held 
Master's degrees in public health.  There comments were taken into consideration.   
A pilot study of 20 questionnaires was conducted at UNRWA clinic in order to test the 
questionnaire. After the pilot study, the question about ethnicity was excluded from the 
questionnaire, and a question about previous smoking was added.  
The questionnaire consisted of ten sections including 114 items. The first section of biographical 
data consisted of 24 questions. Including demographic data such as age, gender, marital status,  
family monthly income, number of medication used per day, and number of skipped doses. The 
last part of this section referred to physiological measures such as weight, height, and blood 
pressure which were measured. 
4.8 Data collection  
The data was collected by an interviewer-administrated questionnaire which was conducted face 
to face by the researcher and by volunteers, students), who were trained to do administer the 
questionnaire. . All of these steps were completed after the patients signed the consent form and 
understood the aim of the study. In order to reduce bias, the questionnaire was administered by 
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trained students and not by the researcher in the UNRWA clinic because the researcher is an 
employee of that clinic.  However, the researcher conducted the questionnaires in the MOH, and 
NGO's clinics. The response rate was 100%. 
At the UNRWA and MOH clinics, the blood pressure was measured by qualified nurses using 
electronic devices which were calibrated by a specialist engineer. While at NGOs clinic, the 
device used to measure the blood pressure was the sphygmomanometer (mercury) because the 
electronic device was not available. 
The weight and height of the respondents were taken by weighing and measuring using a 
weighing scale and height.  The body mass indexes were calculated using the WHO prepared 
tables of BMI according to the following formula, BMI index = weight in kilograms / height 
squared in metres. 
Study duration 
UNRWA:  from11/04/2012 till 09/06/2012. 
Government: from 12/5/2012 till 29/7/2012 
NGO:  from 05/11/2012 till 31/12/2012 
Setting 
Ministry of Health (MOH), UNRWA, NGOs, Palestinian Military Medical Services (PMMS) 
and private for profit are the main health providers of health services. 
MOH carries the heaviest burden of the responsibilitiesof health services in Palestine. 
In the West bank, there are 404 primary health care centers and 54 in the Gaza Strip. 
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The UNRWA currently runs 137 primary health care (PHC) centers and one hospital. In 2010, 
UNRWA medical officers in the PHC centers provided almost 10.4 million consultations, 101 
consultations per physician per day (Global status report, 2010). UNRWA had 20 primary health 
care centers in eight refugee camps in the Gaza Strip and 41 centers in the West Bank (MOH 
report 2010). 
The NGOs sector operates 206 primary health care centers and general clinics, 66 of them in the 
Gaza Strip.  In the West Bank, they operate 140 primary health care centers where PMMS 
operate 23 primary health care centers and clinics, 7of them in the Gaza Strip and 16 distributed 
through different districts in the West bank (MOH annual  health report 2010). 
The study was conducted in primary health care clinics including the Bethlehem Governmental 
clinic, UNRWA (Dehaiashe clinic), and Al Rbayah mobile clinic run by the Palestinian Medical 
Relief Society.  
UNRWA clinic(Dehaishe clinic) is one of the two UNRWA clinics in the Bethlehem district.  
The Dehaishe Camp’s total population is almost13.000 registered refugees. 
The UNRWA clinic in the Dehaishe camp provides health services to the refugee population. 
One of these major services is the non-communicable disease programme. In this program, 899 
patients are registered, 322 male and 577 female. The hypertensive patients represent 439 
patients 165 male and 274 female, 433 of those patients are on medications and 6 of them are on 
lifestyle modification plans according to the clinic report at the end of 2010. 
 
The NGOsPalestinian Medical Relief Society's mobile clinic's free program serves seven villages 
in the Bethlehem district. The biggest one is Al Rbayah and Shawawreh, but they also serve Jort 
Al Shamah, Rakhamh, Al-Uqban, Jub- Altheb, and Kesan. The daily program serves more than 
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seventy patients per day in each clinic. The mobile clinic does not keep separate files for 
hypertensive patients.  
Bethlehem Governmental Health Clinic was chosen for this study as it is the primary health care 
server that provides health services for the non-communicable disease. 
Bethlehem government clinic serves nearly 300 patients. 737 patients visited the Bethlehem 
Government clinic before the separation of the clinic into three major clinics (Beit Sahour, Beit 
Jala, and Al Obadyeh) in February 2012.  246 patients visited the Bethlehem chronic clinic 
between January 2012 and May 2012.  
 
4.9 Ethical consideration 
An official letter of approval was obtained from the director health officer of the West Bank and 
the field disease control officer to proceed in this research. An official letter from Al-Quds 
University was obtained and sent to the public health officer (MOH) and the chief health officer 
of the NGOs at Bethlehem. Each participant received a consent form that explained the study 
purpose and objectives 
4.10 Data analysis 
An Arabic version of the questionnaire was used to save time and to be clear to  the participants; 
the questionnaire was distributed and collected by the researcher and other trained helpers. The 
structure of the interview consisted of ten sections; biographical data, compliance with lifestyle 
modification regimen, compliance with medication regimen, perception of severity, perception 
of risk, perception of benefits, perception of barriers, internal factors, health care provider 
factors, and cues to action. Cronbach (α) coefficient of all sections was 0.88. 
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Section A: Biographical data 
Section A was composed of 24 items which reflected the demographical data (age, gender, 
marital status, smoking, duration of illness, education level, monthly income, number and dose 
of medication, body mass index (BMI) and other data. 
Section B: compliance with the medication regimen 
A 14-item section was used to measure compliance with the medication regimen. The questions 
used a 4- point Likret scale to measure the responses. The response options were always (4), 
frequently (3), rarely (2), never (1). Some questions were formulated in a negative format and the 
scoring was coded in reversed order for example” How often do forget to take your medicine?"  
was coded as follows:  always(1), frequently(2), rarely(3) never(4) 
The compliance score for each item was measured by the mean; a cut point of 3 divided the 
respondents into two groups compliant and non-compliant. Respondents with responses of 3 or 
more were categorized as compliant, and respondents   with responses of less than 3 were 
categorized as non-compliant. This section had a total score of 14 to 56.  
Section C: Compliance with the lifestyle modification regimen 
An 11- item scale was used to measure compliance with the life style modification regimen by 
using 4- point Likret scale to measure the responses.  The response options were always (4), 
frequently (3), rarely (2), never (1). Some questions were formulated in a negative format and the 
scoring was coded in reversed order for example (how often do eat a meal high in animal fat) 
was coded as follows always(1), frequently(2), rarely(3) never(4) 
44 
 
The compliance score for each item was measured by the mean; a cut point of 3 divided the 
respondents into two groups, compliant and non-compliant. Respondents with responses of 3 or 
more   were categorized as compliant, and respondents with responses of less than 3 were 
categorized as non-compliant. The section had a total possible score of 11 to 44. 
Section D: Perception of severity 
A 4- item scale was used to measure the perception of severity of hypertension. A 4- point Likret 
scale was used to measure the responses. The response options were strongly agree(4),agree(3), 
disagree(2), strongly disagree(1). Some questions were formulated in a negative format and the 
scoring was coded in reversed order was coded as follows strongly agree(1),agree(2), 
disagree(3), strongly disagree(4) 
The perception score for each item was measured by the mean. A cut point of 3 divided the 
respondent into two groups those having a high perception of severity with a score of 3 or more 
and those having a low perception of severity with a score of less than 3. The section had a total 
score range of 4 to 16. 
Section E: Perception of risk 
A 9- item scale was used to measure the perception of risk of hypertension that assessed the 
respondent’s perception of having complications from hypertension.  A 4-point Likret scale was 
used to measure the responses. The response options were strongly agree(4),agree(3), 
disagree(2), strongly disagree(1). The perception score for each item was measured by the mean, 
a cut point of 3 divided the respondents into two groups, those having a high perception of risk 
with a response of 3 or more and those having a low perception of risk with a response of less 
than 3.This section had a total score range of 9 to 36. 
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Section F: Perception of benefits 
A7- item scale was used to measure perception of benefits with anti- hypertension drug 
treatment. The responses were measured by using a 4-point Likret scale. The response options 
were extremely beneficial (4), beneficial (3), somewhat (2), not at all beneficial (1). The 
respondents with high perceptions of benefits would be more compliant to treatment than those 
with low perceptions of benefits.The perception score for each item was measured by the mean. 
A cut point of 3 divided the respondents into two groups, those who having a high perception of 
benefits with responses of 3  or more and those having a low perception of benefits with 
responses of less than 3 . The section had a total score range of 7 to 28. 
Section G: Perception of barriers 
A 7- item scale was used to measure the perception of barriers to anti- hypertension drug 
treatment.  A 4-point Likret scale was used to measure the responses. The response options were 
high effect (4), medium effect (3), low effect (2), no effect (1), the barrier score for each item 
was obtained by calculating the mean. A cut point was 3 or more for those having a high 
perception of barriers and less than 3 for those having a low perception of barriers. This section 
had a total score range of 7 to 28. 
Section H: internal factors 
A 14 item section was used to measure the internal factors with anti-hypertension treatment,A 4-
point Likret scale was used to measure the responses. The response options were strongly agree 
(4), agree (3), disagree (2), strongly disagree (1). 
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Question number 7 was e calculated in reversed order; A cutoff point was set at 3.Respondents 
with 3 or  more had  high perceptions of internal factors while a low perception of internal 
factors had  responses of  less than  three with the exception  of question 7 which had a reverse 
scale in which  respondents with responses of3 or  more hadhigh perceptions of  internal factors, 
and those respondents with responses of less than 3 had low perceptions of  internal factors. The 
section had a total score range of 14 to 56. 
Section I: Health care provider factors 
A-12 item response was used to measure the health care provider factors that affect the 
compliance with medication and lifestyle modification regimen. A 4-point Likret scale was to 
measure the responses. The response options were strongly agree (4), agree (3), disagree (2), 
strongly disagree (1). A cutoff point was set at 3. Respondents with responses of 3 or more had a 
high health care provider factor score, while a response of less than 3 had a low health care 
provider scorewith the exception of question 7 which had a reverse scale.  The section had a total 
score range of 12 to 48. 
Section J: Cues to action:  
A-12 item response section was used to measure cues that motivate compliance to anti- 
hypertension treatment. A 4-point Likret scale was used to measure the responses. The response 
options were strongly agree (4), agree (3), disagree (2), strongly disagree (1). 
A cutoff point was set at 3. Respondents with responses of 3 or more were determined to have 
high cues to action, while respondents with responses of less than 3 were determined to have low 
cues to action. The section had a total score range of 12 to 48. 
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4.11 Summary 
The study used quantitative design in exploring the factors that affect compliance to anti- 
hypertension treatment by using pre used questionnaires. The researcher and the training helpers 
filled out the questionnaires face to face, and the data was analyzed by using version nineteen of 
the SPSS. 
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Chapter five 
Research findings 
5.1 Introduction 
This quantitative descriptive-co relational study was conducted in the Bethlehem District at 
primary health care clinics (UNRWA, government, NGOs) using structured interviews of 300 
respondents from the three clinics.The first section, biographical data, consisted of 24 questions 
on demographical data such as age, gender, marital status, smoking, duration of illness, 
education level, monthly income, number and dose of medication, body mass index (BMI) and 
other data. The information given was double checked with information from the patient’s files.  
5.2. Biographical Data  
This section presents data about demographical data such as age, gender, educational status, 
marital status, employment status, duration of illness and physiological parameters of blood 
pressure, body mass index (weight (kg)/(Height in meter square). 
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5.2.1 Gender of the respondent: N=300 
The sample consists of 300 respondent, 103 male and 197 female (34.3%, 64%).100 respondent 
from each clinic, UNRWA, Government, NGO. The UNRWA sample was 36% male and64% 
female. The Government clinic sample was 31% male and 69% female. The NGO's clinic sample 
was 36% male 64% female as shown in the following Table (5.1). 
Table 5.1: Sex of respondents 
 
5.2.2 Age of respondents: 
Item A5 of the interview was about the age of the respondent as showed in table (5.2). The 
respondents were grouped into six categories for analysis. The majority of respondents from the 
UNRWA and government were from the age range 45-54 while the majority of respondents from 
the NGO were concentrated in the 55-64 age range. 97.7% of the respondent’s from UNRWA, 
government, NGO, were aged 35-80as hypertension is mostly found in the adults. 
Table 5.2: Age of respondents 
 
Age 
Total 
 respondent% 
UNRWA 
respondent  % 
Government 
respondent  % 
NGO 
respondent  % 
28-34 2.3% 3.0% 3.0% 1.0% 
35-44 10.3% 8.0% 13.0% 10.0% 
45-54 34.7% 49.0% 32.0% 23.0% 
55-64 26.0% 22.0% 19.0% 37.0% 
65-74 18.7% 9.0% 21.0% 26.0% 
75-80 8.0% 9.0% 12.0% 3.0% 
 
Sex Total 
respondents% 
UNRWA 
respondents % 
Government 
respondents % 
NGOs 
respondents% 
Male 34.3% 36.0% 31.0% 36.0% 
Female 65.7% 64.0% 69.0% 64.0% 
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5.2.3 Marital status: 
The marital status of the respondents is presented in the table below (5.3). The majority of all 
respondents, 77%, were married, followed by 18%of respondents who were widows. The 
majority of respondents for UNRWA, government, and NGOs are as follows respectively 81%, 
70%, 80%. 
Table 5.3: marital status of the respondents 
Marital 
status 
%Total  
respondents 
UNRWA 
respondents 
Government
respondents 
NGO 
respondents 
Single 3.3% 1.0% 7.0% 2.0% 
married 77.0% 81.0% 70.0% 80.0% 
divorced 0.7% 0.0% 0.0% 2.0% 
separated 1.0% 1.0% 0.0% 2.0% 
widow 18.0% 17.0% 23.0% 14.0% 
 
5.2.4 Educational status: 
The majority of respondents table(5.4), 44%, had completed primary school, the majority 
ofUNRWA and the government respondents completed primary school followed by secondary 
school, (42%, 46%, 44%) respectively.  
Table 5.4: Level of education that have been completed 
Educational status Total 
respondent %
UNRWA 
respondent % 
Government 
respondent % 
NGO 
respondent % 
No schooling 16.3% 10.0% 18.0% 21.0% 
Just know reading 7.3% 5.0% 4.0% 13.0% 
Primary school 44.0% 42.0% 46.0% 44.0% 
Secondary school 20.0% 24.0% 19.0% 17.0% 
diploma 5.7% 9.0% 8.0% 4.0% 
Bachelors(BA) 6.3% 10.0% 1.0% 1.0% 
Higher than BA 0.3% 0.0% 1.0% 0.0% 
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5.2.5 Employment status: 
In this item the following table (5.5) represented the employment status of the respondent; the 
majority of them were un-employed (65%), most of them were females 56.7%. 
Table 5.5: Employment status of the respondent 
Employment status Total 
respondents % 
UNRWA 
respondents % 
Government 
respondents% 
NGO 
respondents % 
Gender 
M F M F M F M F 
Governmental employee 2.0% 3.3% 2.0% 5.0% 3.0% 5.0% 1.0% 0.0% 
Non-governmental 
employee 
26.0% 0.7% 2.0% 1.0% 1.0% 1.0% 5.0% 0.0% 
Self employed 19.6% 4.3% 18.0% 7.0% 16.0% 1.0% 25.0% 5.0% 
Retired 1.7% 0.7% 3.0% 2.0% 2.0% 0.0% 0.0% 0.0% 
Un-employed 8.3% 56.7% 11.0% 49.0% 9.0% 62.0% 5.0% 59.0%
 
5.2.6 Monthly Income: 
The majority, 69.6% of the average monthly income in shekels of the respondents was between 
0-1999. 54% of UNRWA respondents' average monthly salary was between 0-1999. The 
majority, 74% of the governmental clinic's respondents' average monthly salary was between 0-
1999, and the majority, 81%of the NGO's clinic's respondents' average monthly salary ranged 
between 0-1999. 
Table 5.6:   Average Monthly income 
Monthly income in 
shekels 
Total 
respondents% 
UNRWA 
respondents% 
Government 
respondent% 
NGO 
respondent% 
0-999 39.3 28.0 52.0 38.0 
1000-1999 30.3 26.0 22.0 43.0 
2000-2999 18.7% 26.0% 12.0% 18.0% 
More than 3000 11.7% 20.0% 14.0% 1.0% 
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5.2.7 Blood pressure of respondent: (N=300) 
Hypertension was defined as systolic blood pressure equal to or greater than 140 mm Hg or 
diastolic blood pressure equal to or greater than 90. The mean systolic blood pressure of total 
respondents for males was 139, and the mean diastolic was 82.2. For females, the mean systolic 
blood pressure was 133.6, and the mean diastolic was 79.7.  For the UNRWA, the mean systolic 
blood pressure for males was 134.2, and the diastolic was 81.2. For females, the mean systolic 
blood pressure was 131.4, and the diastolic was 76.5. Government respondents showed that the 
systolic blood pressure for males and females was 139.8 and 129.43 respectively. The diastolic 
blood pressure for the government respondents was 81.5 for the males and 77.75 for the females. 
The NGO's mean systolic blood pressure was 145.1for the males and 140.54 for the females. The 
diastolic blood pressure was 83.86 for the males and 84.81for the females. 
Table 5.7: Blood pressure of respondent: (N=300) 
Blood pressure Total 
respondents 
UNRWA 
respondents 
Government 
respondents 
NGO 
respondents 
M F M F M F M F 
Systolic blood 
pressure. 
139 133.6 134.2 131.4 139.8 129.4 145.1 140.5 
Diastolic blood 
pressure 
82.2 79.7 81.2 76.5 81.5 77.78 83.86 84.81 
 
5.2.8 Body mass index: 
After measuring the weight in kilograms using a ground scale and then measuring the height in 
meters, tables of body mass index values were used to find the BMI of the patients. In table 
(5.8)3.7 % of the total respondents' body mas indexes were a normal body weight. 26% were 
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overweight, and 70.3 % were obese, more than half of which were females. These results are 
interesting, since obesity plays an important role in blood pressure control. 
Table 5.8: body mass index of respondents 
 
5.2.9 Duration of illness: 
The majority, 57.3% of the respondents had been diagnosed with hypertension for five years or 
more. The UNRWA, Governmental, and NGO's respondents, 64%, 47%, 61%, had high blood 
pressure for five years or more showing that the majority of the respondents had been diagnosed 
with hypertension for five years or more. 
Table 5.9: Duration of illness of the respondents 
 
Duration of illness 
Total 
respondent 
% 
UNRWA 
respondent  
% 
Government 
respondent  
% 
NGO 
respondent 
% 
More than 1 year 11.3 11 17 6 
2 years and more 10.7 13 14 5 
3 years and more 9.7 4 12 13 
4 years and more 11 8 10 15 
5 years and more 57.3 64 47 61 
 
 
 
BMI Total 
Respondents 
UNRWA 
Respondents 
Government 
Respondents 
NGOs 
Respondents 
M F M F M F M F 
Normal body 
weight 
1.7% 2.0% 2.0% 3.0% 2.0% 1.0% 1.0% 2.0% 
Over weight 11.0% 15.0% 12.0% 11.0% 7.0% 12.0% 14.0% 22.0% 
Obese 21.7% 48.6% 22.0% 50.0% 22.0% 56.0% 21.0% 40.0% 
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5.2.10 Reported health complications by respondent at time of the interview: 
The total number of problems was 543 problems for the total respondents, 177 respondents have 
no complications (32.6%) as showed in table (5.10). The highest percentage of complications for 
the three sectors, UNRWA, Government, and NGO, was forswelling of the legs followed by 
heart problems. The patient’s records were checked in order to check the validity of the patients' 
information while the governmental clinic's respondents' complications were checked through 
the doctors.  However, the NGO's did not provide documented evidence about the respondents' 
complications because they do not keep separated files for hypertensive patients. 
Table 5.10 Respondent's health complications at time of interview: 
Health problems Total respondent UNRWA Government NGOs 
None 32.6% 51.0% 28.8% 23.1% 
Heart problems 11.6% 8.4% 11.4% 14.1% 
Palpitation 7.4% 6.3% 8.5% 7.0% 
Visual impairment 5.3% 3.5% 6.0% 6.0% 
Swelling of the feet 7.9% 4.2% 8.5% 10.1% 
Swelling of the legs 61.0% 3.5% 9.0% 5.0% 
Angina 1.8% 2.0% 3.0% 1.0% 
Kidney problems 2.4% 2.1% 3.0% 2.0% 
Dyspnea on exertion 20.1% 16.0% 20.0% 23.1% 
Dyspnea at rest 4.8% 3.5% 2.0% 8.5% 
Paralysis 0.0% 0.0% 0.0% 0.0% 
Total 100% 100% 100% 100% 
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5.3 Compliance with Anti-hypertension Drug Treatment 
5.3.1 Number of medications which the total respondents were taking for hypertension: 
The majority, 37.3 %, of respondents took one medication, 35.3%took two kinds, and the 
medical records of the patients at the UNRWA were checked for the type of medication in order 
to ascertain the validity of the reported data from the patients.  The pharmacists were asked as 
well as an extra step of assurance. . At the government clinic the doctor and the nurse were asked 
to ensure the patients type of medicine regime, but at the NGO's clinic, the health workers and 
the doctors were asked to check the information. 
Table 5.11: Number of medication taken for high blood pressure treatment 
number of 
medication 
Total 
respondent UNRWA Government NGO 
One 37.7% 24.0% 36.0% 53.0% 
Two 35.3% 41.0% 33.0% 32.0% 
Three 23.0% 31.0% 23.0% 15.0% 
Four 2.7% 3.0% 5.0% 0.0% 
More than four 0.7% 0.0% 2.0% 0.0% 
No medication 0.7% 1.0% 1.0% 0.0% 
total 100% 100% 100% 100% 
  
5.3.2 Dosage of medications respondent were taking: (N=300) 
The majority 48.7%, of the respondents took one dose, 43.7% took two doses and 0.7% of them 
didn’t take any dose, all the respondents didn’t take more than three doses. 
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Table 5.12: Dosage of medication taken per day 
Dose of 
medication 
taken 
Total 
respondent
UNRWA Government NGOs 
One 48.7% 45.0% 49.0% 52.0% 
Two 43.7% 49.0% 43.0% 39.0% 
Three 6.7% 4.0% 7.0% 9.0% 
Four 0.0% 0.0% 0.0% 0.0% 
Five 0.0% 0.0% 0.0% 0.0% 
More than five 0.3% 0.0% 0.0% 0.0% 
Zero dose 0.7% 1.0% 1.0% 0.0% 
 
5.3.3 Dosage skipped in the last three days: 
On the question about the doses that were skipped during the last three days, the respondents 
divide into two groups. Those who didn’t skip any dose of medication during the last three days 
were considered as compliant to the treatment and those who skipped one or more were 
considered as non-compliant. The majority, 69.3%, of the respondents didn’t skip any doses, and 
30.7% skipped one or more doses. 72% of the respondents at the UNRWA, 68% of the 
respondent's at the Government clinic, and 68% of the respondents at the NGO's clinic o didn’t 
skip any doses while 28%, 32 percent, and 32%, respectively, skipped one dose or more.   
Table 5.13: Dosage skipped in the last three days 
Dose of 
medication 
skipped 
Total 
respondent 
UNRWA Government NGOs 
Zero dose 69.3% 72.0% 68.0% 68.0% 
One 17.0% 12.0% 16.0% 23.0% 
Two 4.7% 6.0% 3.0% 5.0% 
Three 5.3% 7.0% 5.0% 4.0% 
Four 0.3% 0.0% 1.0% 0.0% 
Five and more 3.3% 3.0% 7.0% 0.0% 
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5.3.4 Evidence of medication compliance in the last three appointments: 
The patient’s record shows no evidence about compliance to treatment in the three clinics, so it’s 
difficult to compare our results with the recorded notes. 
The first item in section B of the questionnaire asked about how often the respondent took their 
medication. The respondents separated into two groups. Those who took their medication always 
were considered compliant, and the others were considered non-compliant.  This is because the 
hypertensive patient should take their medication on a daily basis. The majority of the 
respondents, 183 or 61%, always took their medication while the other, 117 or 39%, did not 
always take their medication. UNRWA, Government, NGOs, who took their medication on a 
daily basis ,61%, 54%, 68%,respectively, were compliant to their medication while the  39%, 
46%, 32% who didn’t taking their medication on daily basis were considered non-compliant. 
             Table 5.14 medication taking in daily basis 
compliance Total 
respondents%
UNRWA 
Respondents%
Government 
Respondents%
NGOs 
Respondents%
Compliant 61.0 61.0 54.0 68.0 
Non-compliant 39.0 39.0 46.0 32.0 
  
5.3.5 Compliance with clinic appointments and blood pressure monitoring: 
In section B of the questionnaire item B13 asked how often the respondents showed up for clinic 
appointments as scheduled. The respondents were categorized into compliant and non- compliant 
groups based on their responses. The majority of respondents namely 87.3% were compliant 
with clinic appointments while 12.7% were non-compliant. The patients who were committed to 
their clinic appointments were considered to be compliant to their drug regimen treatment.  
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Honoring clinic appointments was considered to be an indicative variable of medication 
compliance. 
The UNRWA respondents' clinic records were checked for their appointments. Most, 28.9%, of 
the respondents were coming on timewhile 4.4% didn’t come on time. Each one had their 
patient’s card which was used for the appointment system of every visit and also used to record 
their blood pressure. 
Government and NGO's patients didn’t have a patient card and there was not an appointment 
system being used.  They visited the clinic only when their medication hadrun out.This meant 
66.6% of respondents did not have a hypertension card. 
Uncontrolled patients at the government clinic came every six month to visit a specialist doctor 
(internist) by appointment while there was not a specialist doctor at the NGO's clinics. 
5.3.6 Compliance as measured on the compliance with medication regimen: 
Section B of the questionnaire measured the compliance with antihypertensive drug treatment; 
descriptive statistics was used to measure the response on this scale. The majority of the 
respondents, 11.3%, stated that the main reason for not complying with their treatment regimen 
was failure to refill their prescriptions, forgetfulness (9.7%), carelessness (7.7%). 
 The majority of the respondents at the UNRWA clinic, 14.0%, stated that the main reason for 
not complying with their treatment regimen was failure to refill their prescriptions.The majority 
of the respondents at the Government clinic15.0% stated that the main reason for not complying 
with their treatment regimen was because they felt better. The majority of the respondents at the 
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NGO clinic (10.0%) stated that the main reason for not complying with their treatment regimen 
was forgetfulness (Table 15.5). 
Table5.15: Reasons for non-compliance with anti-hypertension drug treatment of UNRWA, 
Government, NGOsand Total respondents (*No medication) 
 Agreement with reasons for not 
complying % 
Disagreement with reason for 
non- complying % 
Reasons for not 
complying with 
medication 
UNRWA Gov NGO Total UNRWA Gov NGO Total 
Failure to refill your 
prescription 
14 12 8 11 85* 87* 92 88 
Forgetfulness 6 13 10 10 94 87 90 90 
Carelessness 6 13 4 8 94 87 96 92 
Because they are feeling 
better 
5 15 0 7 95 85 100 93 
Medication side effects 9 10 0 6 91 90 100 94 
Fear of addiction 4 8 2 5 96 92 98 95 
Believe that the 
medication are ineffective 
5 7 1 4 95 93 99 96 
Using of alternative 
remedies 
3 7 0 3 97 93 100 97 
Frequent change of 
medication type 
2 5 0 2 98 95 100 98 
Frequent change of 
medication dosage 
1 3 0 1 99 97 100 99 
 
Table 5.16 summarizes the values of central tendency on the compliance with the medication 
regimen scale of all respondents. As seen in Figure 5.1, the distribution was negatively skewed 
(distribution = -2.525). This indicates that most respondents scored high. Thus clustering of 
scores occurred towards the right which means that most of the respondents tended to be 
compliant with anti-hypertension medications. The mean score for this scale was 3.75 (SD = 
0.37). Respondents with a mean score below 3 were considered non-compliant, and respondents 
with a mean score of 3 and above were considered compliant. 
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 Table 5.16 summarizes the values of central tendency and dispersion on the compliance with the 
medication regimen scale of UNRWA,Government, NGOs respondents. As seen in table 5.16, 
the distribution was negatively skewed,this indicates that most respondents scored high; thus 
clustering of scores occurred towards the right which means that most of the respondents tended 
to be compliant with anti-hypertension medications. The mean score of UNRWA, Government, 
NGOs respondents was (3.69, 3.75, 3.87) respectively. 
Table: 5.16 measures of total respondent’s central tendency on the compliance with medication 
Compliance 
with drug 
treatment 
N Mean SD Median Range of 
scores 
distribution Interquartile 
range 
Total 300 3.75 0.37 3.85 1.5-4.07 -2.525 0.36 
UNRWA 100 3.69 0.34 3.78 1.5-4.0 -3.635 0.34 
Government 100 3.69 0.48 3.85 2.07-4.07 -1.653 0.48 
NGOs 100 3.87 0.36 3.92 2.93-4.07 -1.303 0.36 
 
 
Figure 5.1compliance with drug treatment of total respondents 
61 
 
5.4 Compliance with Lifestyle Modification 
In this section, the researcher intends to answer the following research question: How compliant 
are the respondents with their lifestyle modifications regimen? 
5.4.1 Frequency of smoking:  
The majority of respondents, 249 or 83.7%, did not smoke at all. 16.3%were smokers, 13% of 
them were males and 3.3% were females. The majority of UNRWA, Government, and NGO’s 
respondents (86%, 87%, 78%) didn't smoke as showed in table(5.17). 
Table: 5.17 Frequency of smoking of total respondents, UNRWA, Government, NGO by gender 
Do you 
smoke? 
Total  
respondents 
UNRWA 
respondent 
Government 
respondent 
NGOs 
respondents 
M F M F M F M F 
YES 13 3.3 10 4 8 5 21 1 
NO 21.3 62.3 26 60 23 64 15 63 
  
Most of the respondents 9% were smoked more than twenty cigarettes; 8% of UNRWA 
respondents smoked more than twenty cigarettes, 10% of Government respondents smoked more 
than twenty cigarettes and 12% of NGO respondents smoked more than twenty cigarettes as 
showed in table (5.18) 
Table 5.18: Number of cigarettes smoked per day of total respondents, UNRWA, Government, 
and NGO 
Number of 
cigarettes/day 
Total 
 respondent 
UNRWA 
respondent 
Government 
respondent 
NGOs 
respondent 
N % N % N % N % 
1-4 3 1 0 0 3 3 0 0 
5-9 3 1 1 1 2 2 0 0 
10-14 10 3.3 4 4 2 2 4 4 
15-19 8 2.7 1 1 1 1 6 6 
≥ 20 27 9 8 8 5 5 12 12 
Zero 249 83 86 86 87 87 76 76 
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5.4.2 Previous smoking: 
The majority of respondents, 215 or 71.7%, did not smoke at all, 12% were previously smokers, 
the majority of the UNRWA,Government respondents 72%, didn't smoke previously while the 
NGO's respondents, 71%, didn't smoke previously as showed in table (5.19). 
 
Table 5.19 Frequency of previous smoking of total respondents, UNRWA, Government, and 
NGO 
Previous 
smoking 
Total  
respondents 
UNRWA 
respondents 
Government 
respondents 
NGOs 
respondents 
N % N % N % N % 
Yes 36 12 14 14 15 15 7 7 
No 216 71.2 72 72 72 72 71 71 
Smoking now 49 16.3 14 14 13 12 22 22 
 
5.4.3 Frequency of alcohol consuming: 
The majority of respondents, 97.3%, never consumed alcohol, and 2.7% consumed alcohol with 
little quantity. The UNRWA and NGOs respondents didn’t consume alcohol at all while the 
majority of the Governmental respondents 92% never consume alcohol. 8% of the Governmental 
respondents rarely drank alcohol (table 5.20), (table5.21). 
Table 5.20 Frequency of alcohol consumingof total respondents, UNRWA, Government, and 
NGO 
Do you consume 
alcohol? 
  
Total 
 respondent 
UNRWA 
respondent 
Government 
respondent 
NGOs 
respondent 
N % N % N % N % 
Yes  8 2.7 0 0 8 8 0 0 
No  292 97.3 0 0 92 92 0 0 
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Table 5.21 Quantity of alcohol consumingof total respondents, UNRWA, Government, and NGO 
Quantity of  
alcohol 
consumed 
Total  
respondents 
UNRWA  
respondents 
Government  
respondents 
NGOs  
respondents 
N % N % N % N % 
little 2.0 0.7 0.0 0.0 2.0 2.0 0.0 0.0 
rarely 6.0 2.0 0.0 0.0 6.0 6.0 0.0 0.0 
not atall 292 97.3 0.0 0.0 92 92 0.0 0.0 
 
5.4.4. Compliance with the lifestyle modification regimen: 
The total items of section C measured the compliance to lifestyle modifications among 
respondents, the behaviors divided into two categories: 6 recommended and 5 non recommended 
behaviors as showed in tables (5.22-5.23). 
Table5.22: frequencies of responses on the compliance with life style modifications 
(recommended   behaviors) of total respondents, UNRWA, Government, and NGO 
 
 UNRWA 
respondents % 
Government 
respondents % 
NGO 
 respondents % 
Total 
respondents % 
How often do you? Compliant Compliant Compliant Compliant 
Eat vegetables 90.0 95.0 97.0 94.0 
Eat fruits 90.0 78.0 85.0 84.4 
Relax 74.0 85.0 79.0 79.3 
Get enough sleep 72.0 63.0 86.0 73.7 
Try to lose some weight 64.0 63.0 18.0 48.3 
Doing physical exercise 70.0 24.0 9.0 21.0 
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Table 5.23 frequencies of responses on the compliance with life style modifications (non-
recommended behaviors) of total respondents,UNRWA, Government, and NGO 
 
How often do you? 
UNRWA 
respondents%
Government 
respondents % 
NGO 
respondents% 
Total 
respondents%
Compliant Compliant Compliant Compliant 
Drink alcohol 100.0 100.0 100.0 100.0 
Smoke 89.0 90.0 80.0 86.3 
Eat fast food 89.0 97.0 79.0 93.0 
Sprinkle salt on your food 91.0 91.0 79.0 87.0 
Eat a meal with high animal fat 69.0 82.0 74.0 75.0 
 
The distribution of the respondent's score for this scale as plotted in figure 5.2 is negatively 
skewed (distribution = -0.664) indicating that most respondents had high scores on the scale. 
This indicates that the majority of the respondents tended to be compliant to lifestyle 
modifications. In table 5.24 below, the median was 3.18 for all respondents. The inter-quartile 
range was 0.36, and the mean score for this section was 3.15, Table (5.24.). The mean scale score 
of individual respondents' scores was used to catagorise the respondents into compliant and non 
compliant groups to facilitate correlational and infrential statistice. Respondents with a mean 
score of below 3 were considerd noncompliant with recommended life style modifications, and 
respondents with a mean score of 3 and above were considered  compliant.  The least  compliant 
group came from the NGO's clinic (3.04)  (Table 5.24). 
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Table 5.24 Measures of central tendency and dispersion on the compliance with life style 
modificationof total respondents, UNRWA, Government, and NGO. 
Compliance with 
life style 
modifications 
N Mean SD Median Range of 
scores 
distribution Interqu
artile 
range 
Total 300 3.15 0.31 3.18 2.09-3.82 -0.664 0.36 
UNRWA 100 3.18 0.356 3.2 2.18-3.82 -0.976 0.45
Government 100 3.22 0.255 3.18 2.64-3.82 -0.039 0.45 
NGOs 100 3.04 0.285 3.09 2.09-3.55 -0.761 0.43 
 
 
 
Figure 5.2 Compliance withlife style modifications of total respondents 
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5.5 Respondent perception of severity of hypertension 
The responses were collapsed into two categories: high and low perception of severity, the 
majority of total respondents, 88.6 %, consider their condition serious,as showed in table (5.25). 
Table 5.25 perception of severity of total respondents, UNRWA, Government, and NGO  
 
To what extant do agree with the 
following statements? 
UNRWA 
respondents 
Government 
respondents 
NGOs 
respondents 
Total 
respondents 
High 
perception of 
severity% 
High 
perception of 
severity% 
High 
perception 
of severity%
High 
perception 
of severity 
My blood pressure condition is 
serious. 
91.0 85.0 90.0 88.6 
I am not worried about my condition 
because I don’t have any symptoms 
79.0 79.0 81.0 79.0 
I think I am cured because I don’t have 
symptoms 
76.0 79.0 79.0 78.6 
I am worried about my blood pressure 
condition because I have symptoms. 
62.0 58.0 72.0 67.4 
 
The following Table (5.26) summarizes the central tendency values of the perception of severity. 
The data was negatively skewed which indicates that the respondents score was high on the scale 
(distribution = -0.732). The median score was 3.0, and the mean was 2.93 which mean that the 
respondents tend to be non-compliant with perception of severity. 
Table 5.26 Measures of central tendency and dispersion on perception of severity of total 
respondents, UNRWA, Government, and NGO  
 N Mean SD Median Interquartile 
range 
distribution Rang of 
scores 
Total 300 2.935 0.43 3 0.5 -0.732 1.25-4.0 
UNRWA 100 2.937 0.41 3 0.5 -0.281 1.75-4.0 
Government 100 2.935 0.5 3 0.5 -0.981 1.25-4.0 
NGOs 100 2.932 0.37 3 0.25 -0.683 1.75-3.75 
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5.6 Respondents perception of their risk of developing hypertension 
Section E measured the respondents’ perception of their risk of developing complications, 86% 
of the total respondents were perceived to have a risk of stroke (Table 5.27). 
Table 5.27 Perception of risks of total respondents, UNRWA, Government, and NGO  
 
How do view your risk of? 
UNRWA 
respondents
Government 
respondents 
NGOs 
respondents 
Total 
respondents
High risk% High risk% High risk% High risk% 
Having  stroke 82.0 86.0 90.0 86.0 
Developing heart problems 78.0 81.0 93.0 84.0 
Developing visual impairment 76.0 82.0 88.0 79.0 
Affecting negatively family life 74.0 77.0 86.0 78.7 
Becoming a burden for your family 72.0 76.0 83.0 77.3 
Developing kidney problems 71.0 71.0 82.0 74.3 
Developing paralysis 60.0 71.0 81.0 71.0 
Affecting negatively social life 56.0 60.0 79.0 68.0 
Affecting career negatively 40.0 20.0 44.0 34.7 
 
The following Table (5.28) summarizes the values of the central tendency of the respondent's 
perception of risk and the distribution of data. The data was negatively skewed, which indicates 
that they tend to have a high perception of risk. The mean score was 3.26 indicating that the total 
respondents were compliant to perception of risk. 
Table 5.28: Measurement of central tendency on perception of riskof total respondents of total 
respondents, UNRWA, Government, and NGO  
central tendency 
perception of 
risk 
N Mean SD Median Interquartile 
range 
distribution Rang of 
scores 
Total 300 3.26 0.59 3.3 0.89 -0.0446 1.56-4.11 
UNRWA 100 3.19 0.66 3.2 1.11 -0.286 1.56-3.44 
Government 100 3.6 0.65 3.4 1.11 -0.665 1.5 - 3.43 
NGOs 100 3.21 0.45 3.2 0.33 -0.45 2.0-4.11 
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5.7 Perception of benefits of ant hypertension treatment 
In this section, perception of benefits of anti- hypertension treatment respondents was measured 
by using descriptive statistics. The responses were collapsed into two categories: positive and 
negative perception. The Table below (5.29) showed the positive and negative perceptions in 
order of importance. The most important benefits were avoiding added financial stress to treat 
complications (95.7%), followed by keeping blood pressure under control (93.7%), protecting 
from complication (93.6%), increasing life quality (93%), increasing the sense of wellbeing 
(89%), giving peace of mind (82%), and decreased chance of dying (44.7%). 
Table 5.29 perceptions of benefits of total respondents, UNRWA, Government, and NGO  
How do you view the benefits of 
complying with doctor's treatment? 
UNRWA 
respondents 
Government 
respondents 
NGOs 
respondents 
Total  
respondents 
Positively 
perception 
of benefits%
Positively 
perception 
of benefits%
Positively 
perception 
of benefits% 
Positively 
perception 
of benefits% 
Avoiding added financial to treat 
complication 
97.0 96.0 96.0 95.7 
Keeping my blood pressure under 
control 
96.0 95.0 95.0 93.7 
Protecting me from complication 96.0 93.0 95.0 93.6 
Increasing my quality of life. 95.0 93.0 93.0 93.0 
Increasing my sense of wellbeing. 89.0 91.0 91.0 89.0 
Giving me peace of mind (Raht- bal). 86.0 88.0 77.0 82.0 
Decreasing my chance of dying. 57.0 39.0 38.0 44.7 
 
Table 5.30 summarizes the values of central tendency for the Perception of benefits. The data 
was negatively skewed, (distribution = -0.732). This indicates that the average score of most 
respondents was high on the scale which implies that they tend to have high perception of 
severity. 
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Table 5.30 Measures of central tendency and dispersion on perception of benefits of total 
respondents, UNRWA, Government, and NGO  
central tendency 
of perception of 
benefits 
N Mean SD Median Inter-
quartile 
rang 
distribution Rang of 
scores 
Total 300 3.24 0.53 3.28 0.86 -0.545 1.0-4.0 
UNRWA 100 3.32 0.51 3.28 0.71 -0.53 1.47-4.0
Government 100 3.25 0.57 3.28 0.86 -.086 1-4 
NGOs 100 3.14 0.51 3.00 0.86 -0.209 1.57-4.0 
 
5.8 Perception of barriers to anti-hypertension treatment: 
The responses were collapsed into high and low perception of barriers as shown in the following 
Table (5.31).The most prevalent barrier was the lack of motivation to be cured with 8.4%.  
Table 5.31 perception of barriersof total respondents, UNRWA, Government, and NGO  
Which aspects are problematic and 
preventing you from complying with 
your treatment? 
UNRWA 
respondents 
Government 
respondents 
NGOs 
respondents 
Total  
respondents 
High 
perception 
of barriers% 
High 
perception of 
barriers% 
High 
perception 
of barriers% 
High 
perception 
ofbarriers% 
Lack of motivation because I can't be 
cured. 
5.0 12.0 12.0 8.4 
Ineffectiveness of the medicine to 
stabilize my blood pressure. 
7.0 6.0 6.0 6.0 
Not having enough time to exercises. 6.0 1.0 1.0 3.6 
Having sleeping problems 2.0 6.0 6.0 3.3 
Lack of time to relax 2.0 3.0 3.0 2.3 
Lack of discipline with the dietary 
regimen. 
5.0 2.0 2.0 1.7 
Lack to discipline to stop smoking. 2.0* 0.0* 0.0* 0.6
 
*31 didn’t smoke of UNRWA, *87 didn’t smoke of government, *32 of NGOs didn’t smoke 
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Table 5.32 summarizes the values of central tendency for the Perception of Barriers Scale. The 
median was 1.57, and the interquartile range was 0.57. The distribution was positively skewed to 
the right which means respondents generally scored low on this scale; this means that the 
respondents tended to have low perceptions of the stated barriers. 
Table 5.32 Measures of central tendency perception of barriersof total respondents, UNRWA, 
Government, and NGO  
 
 
central tendency 
perception of 
barriers 
N Mean SD Median Inter-
quartile 
rang 
distribution Rang of 
scores 
Total 300 1.45 0.41 1.57 0.57 0.986 1-3.14 
UNRWA 100 1.34 0.42 1.14 0.57 1.20 1.0-3.0 
Government 100 1.64 0.32 1.57 0.45 1.29 1-2.86 
NGOs 100 1.37 0.42 1.21 0.68 1.516 1-3.14 
 
 
5.9 Perception of internal factors related to treatment compliance 
Section H of the questionnaire used to measure the extent to which internal factors affect 
respondent's compliance with anti-hypertension treatment. The responses collapsed into high and 
low internal factors scores for discussion purpose. The most important internal factors of the 
total respondents were that they were aware of how their body health feels (98.7%); their 
physical health was determined by what they did and did not (98.3%) as showed in Table (5.33). 
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Table 5.33- perception of internal factors of total respondents, UNRWA, Government, and NGO  
To what extant do you agree with 
the following statements? 
UNRWA 
respondents 
Government 
respondents 
NGOs 
respondents 
Total  
respondents 
High score  
of internal% 
High score  
of internal % 
High score 
of internal% 
High score 
of internal% 
I am aware of how healthy my 
body feels 
96.0 100.0 100.0 98.7 
My physical health is determined 
largely by what I do and what I 
don’t do. 
96.0 91.0 100.0 98.3 
I notice immediately when my 
body does not feel healthy. 
97.0 100.0 97.0 98 
I understand why it is necessary to 
take my medicine as prescribed. 
99.0 97.0 97.0 97.7 
I am in charge of my physical 
health 
98.0 98.0 95.0 97 
I understand how my medication 
works to keep my blood pressure 
under control. 
96.0 100 99.0 96.3 
I understand the nature of my 
condition. 
96.0 91.0 95.0 94 
I am primarily responsible for 
managing my hypertension. 
78.0 88.0 98.0 90.6 
I think that I can cure my 
hypertension with local herbs other 
than the prescribed medicine. 
78.0 87.0 82.0 88.3 
I understand what I can do to keep 
my blood pressure. 
86.0 81.0 78.0 87.3 
I understand what caused my blood 
pressure condition. 
82.0 80.0 86.0 82.3 
I understand the meaning of my 
blood pressure reading 
79.0 71.0 79.0 76.3 
I have the ability to manage my 
hypertension. 
74.0 75.0 73.0 74 
My doctor is primarily responsible 
to manage my hypertension. 
54.0 55.0 67.0 59.6 
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Table 5.34 summarizes the values of central tendency for the Internal Factors Scale. The median 
was 3.28, and the interquartile range was 0.51. This indicates that the respondents scored low on 
this scale. The distribution is negatively skewed to the left which means that the respondents 
have high perception of internal factors. Except for the NGO's respondents, the distribution is 
positively skewed to the right which means that the respondents score low on this scale and the 
NGOs respondents tend to have low perception of internal factors. 
Table 5.34 Measures of central tendency of internal factorsof total respondents of total 
respondents, UNRWA, Government, and NGO  
 N Mean SD Median Inter-quartile 
rang 
distribution Rang  
of scores 
Total 300 3.30 0.338 3.28 0.50 -0.027 2.29-4.0 
UNRWA 100 3.39 0.34 3.35 0.50 -0.406 2.29-4.0 
Government 100 3.36 0.35 3.35 0.64 -0.255 2.43-4.0 
NGOs 100 3.15 0.26 3.14 0.36 1.516 2.55-3.93 
 
5.10 Perception of health care provider factors to hypertension treatmentof 
total respondents, UNRWA, Government, and NGO   
Section I measures the respondent's health care provider factors by using descriptive statistics. 
The responses collapsed into positive and negative perceptions. By referring toTable (5.35), the 
majority of respondents said that the doctors treated them with respect (98%), the doctor 
explained how they should manage their blood pressure (79.6%), and the waiting time was 
acceptable (76.7%). 
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Table 5.35Health care provider’s perceptions of total respondents UNRWA, Government, and 
NGO  
To what extant do you agree with 
the following statements? 
UNRWA 
respondents 
Government 
respondents 
NGOs 
respondents 
Total  
respondents 
Positive 
perception%
Positive 
perception%
Positive 
perception% 
Positive 
perception%
The doctors treat me with respect 95.0 99.0 100.0 98.0 
The health care workers treat me 
with respect. 
95.0 95 100.0 96.7 
The doctor patient with me.  90.0 95.0 99.0 94.0 
I have confidence in the doctor. 94.0 92..0 97.0 93.7 
The doctor listens to my concerns. 94.0 93.0 91.0 92.7 
The doctor who treats me at the 
clinic is experienced. 
94.0 90.0 91.0 91.7 
The medicine I receive at the clinic 
is effective. 
87.0 94.0 94.0 91.7 
The doctor understands my 
concerns. 
91.0 93.0 91.0 91.0 
The doctor explains my condition 
to me. 
90.0 88.0 70.0 86.0 
The medicine is available when I 
need it. 
92.0 88.0 85.0 85.0 
The doctor explains to me how I 
should manage my blood pressure 
condition. 
87.0 87.0 80.0 79.6 
The waiting time in acceptable. 77.0 80.0 73.0 76.7 
 
Table 5.36 summarizes the values of central tendency of the Health Care Provider Scale. This 
score indicates that the respondents had positive perceptions of the health care provider factors. 
The median was 3.08, and the interquartile range was 0.67. The mean score for this scale was 
3.197 (SD = 0.401) (refer to table 5.45). The mean scale score of individual respondents was 
used to categorize the respondents into positive and negative perceptions of health care provider 
factors. Respondents with a mean score below 3 were considered as having a negative perception 
of health care provider factors, and respondents with a mean score of 3 and above were 
considered as having a positive perception of health care provider factors. 
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Table 5.36 central tendency of respondent perception to health care providerof total respondents, 
UNRWA, Government, and NGO  
Centraltendency of 
perception to health 
care provider 
N Mean SD Median Inter-
quartile 
rang 
distribution Rang of 
scores 
Total 300 3.197 0.401 3.08 0.67 0.22 2.17- 4.0 
UNRWA 100 3.34 0.42 3.14 0.73 -0.355 2.17- 4.0 
Government 100 3.23 0.43 3.12 0.75 0.048 2.25- 4.0 
NGOs 100 3.02 0.326 3 0.25 0.983 2.25-4.0 
 
5.11 Perception of the cues to action factors of total respondentsof total 
respondents, UNRWA, Government, and NGO  
This section uses descriptive statistics to measure what extent the stated cues motivated the 
compliance of anti-hypertension blood treatment. The responses collapsed into positive and 
negative motivations. Table (5.37) summarizes these findings. 
An overwhelming majority of the respondents said the advice from the doctor (99%)and from 
health care workers (96.3%) motivated them to comply with their medications; advice from 
doctors was the most important cues to action which reflects the important rule of the doctors 
and the health care providers.  Other important motivations included the respondent feeling 
unwell (97.9%),  
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Table 5.37 Perception of cues to action of total respondents, UNRWA, Government, and NGO  
 
Which of the following motivates 
you to comply with your blood 
pressure? 
UNRWA 
respondents 
Government 
respondents 
NGOs 
respondents 
Total  
respondents 
Motivated% 
 
Motivated% 
 
Motivated% 
 
Motivate% 
 
Advice from doctor 98.0 99.0 100.0 99.0 
When I feel unwell. 97.0 98.0 98.0 97.7 
Advice from a health care worker 
other than doctor. 
96.0 96.0 97.0 96.3 
TV programs on high blood 
pressure 
78.0 85.0 83.0 82.0 
Advice from family member. 82.0 85.0 76.0 81.0 
Health education leaflets given to 
me. 
78.0 76.0 84.0 79.3 
Newspaper or journal article. 76.0 73.0 67.0 72.0 
Advice from my friends. 71.0 71.0 66.0 69.4 
Death of a relation or friend due 
to high blood pressure. 
65.0 65.0 73.0 67.6 
Health posters displayed 79.0 81.0 30.0 63.3 
Radio programs about blood 
pressure 
66.0 74.0 44.0 61.3 
Information from the internet. 67.0 54.0 26.0 48 
 
Table (5.38) summarizes the values of central tendency of the Cues to Action Scale. This 
indicates that the respondents scored high on this scale. The median was 3.08, the mean is less 
than three which means that the respondents' perception have low score on the cues to action. 
Table 5.38 measures of central tendency and dispersion of cues of actionof total respondents, 
UNRWA, Government, and NGO  
central tendency 
of cues of action 
N Mean SD Median Inter-
quartile 
rang 
distribution Rang of 
scores 
Total 300 3.09 0.48 3.08 0.67 -0.205 1.42-4.08 
UNRWA 100 3.18 0.46 3.12 0.75 -0.044 2.0-4.08 
Government 100 3.21 0.48 3.16 0.65 -0.145 2.0-4.00 
NGOs 100 2.9 0.44 2.92 0.42 0.079 1.42-4.0 
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5.12 Relations between the research variables 
In this section, the relation between theoretical variables and the treatment compliance is 
discussed to investigate the co-relational and the inferential statistics. 
Treatment compliance expressed both compliance with drug treatment and compliance with life 
style modifications. Treatment compliance was measured by combining section B and section C. 
Referring to the health belief model, the relationship between the compliance and the following 
factors was investigated: socio-demographic factors, perception of severity, perception of risk, 
perception of benefits, perception of barriers, perception of internal factors, healthcare provider 
factors, and cues to action. 
5.12.1 Relationships between the demographic characteristics and treatment compliance: 
In this section, the relationship between the treatment compliance and the biographical variables 
were discussed. 
What is the relationship between the treatment compliance and the following variables among 
patients diagnosed with hypertension; socio-demographic factors (age, gender, marital status, 
educational status, work status, monthly income); physiological factors (body mass index, 
duration of illness; number of medication prescribed; doses of medication took; doses of 
medication skipped; number of cigarettes smoked; number of cigarettes smoked previously; 
complications of the disease; and quantity of alcohol intake? 
The chi square test was used to answer this question with 95% level of confidence. The findings 
were as follows: As shown in the table (5.39) below, of the total respondents, there was no 
significant relationship between the socio-demographic factors and the treatment compliance. 
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Age (chi-square= 4.71 P-value=0.452), gender (chi-square= 1.84 P-value=0.175), marital status 
(chi-square=0.890 p-value=0.926), educational status (chi-square=3.76 p- value=0.709), 
occupational status (chi-square=3.409 p-value=0.492), monthly income (chi- square=1.529 p-
value=0.676). 
With regards to physiological factors, there was a strong relationship between the doses skipped 
per day and the treatment compliance (chi-square=52.241 p= 0.00 as showed in table(5.40). 
Analysis of variance (ANOVA) test was done to test for statistically significant differences 
between the means of compliant and non-compliant groups. Significant differences were found 
between the means of medication compliance and the doses skipped per day. The respondents 
who skippedone or more doses were less compliant than those who didn’t skip any doses (13.8 
p-value= 0.000). 
Table 5.39 Socio-demographic factors of total respondents, UNRWA, Government, NGO and 
compliance  
 
Variable 
UNRWA 
respondents 
Government 
respondents 
NGOs 
respondents 
Total  
respondents 
p- 
value 
signifi
cance 
p- 
value 
signifi
cance 
p- 
value 
signifi
cance 
p- 
value 
signifi
cance 
Age 0.216 Not 
sig 
0.681 Not 
sig 
0.829 Not 
sig 
0.452 Not 
sig 
Gender 0.035 Sign 0.874 Not 
sig 
0.677 Not 
sig 
0.175 Not 
sig 
Marital status 0.745 Not 
sig 
0.677 Not 
sig 
0.691 Not 
sig 
0.926 Not 
sig 
Educational status 0.099 Not 
sig 
0.769 Not 
sig 
0.037 Sig 0.709 Not 
sig 
Occupational status 0.073 Not 
sig 
0.537 Not 
sig 
0.03 Sig 0.492 Not 
sig 
Monthly income 0.274 Not 
sig 
0.316 Not 
sig 
0.577 Not 
sig 
0.676 Not 
sig 
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Table 5.40 - Physiological factors of the total respondent,UNRWA, Government, NGO and 
compliance 
 
Variable 
 
 
UNRWA 
respondents 
Government 
respondents 
NGOs 
respondents 
Total  
respondents 
p- 
value 
signifi
cance 
p- 
value 
signifi
cance 
p- 
value 
signifi
cance 
p- 
value 
signifi 
cance 
Body mass index 0.598 Not 
sig 
0.013 Sig 0.899 Not 
sig 
0.069 Not 
sig 
Number of 
medication 
0.43 Not 
sig 
0.178 Not 
sig 
0.114 Not 
sig 
0.445 Not 
sig 
Duration of illness 0.165 Not 
sig 
0.767 Not 
sig 
0.861 Not 
sig 
0.791 Not 
sig 
Dose skipped in the 
last three days 
0.035 Sig 0.000 Sign 0.819 Not 
sig 
0.00 sig 
Number of cigarettes 
smoked per day 
0.931 Not 
sig 
0.354 Not 
sig 
0.517 Not 
sig 
0.299 Not 
sig 
Number of cigarettes 
smoked previously 
0.818 Not 
sig 
0.95 Not 
sig 
0.997 Not 
sig 
0.979 Not 
sig 
Number of years of 
smoking 
0.645 Not 
sig 
0.789 Not 
sig 
0.789 Not 
sig 
0.998 Not 
sig 
Quantity of alcohol 
intake 
const
ant 
Not 
sig 
0.727 Not 
sig 
const
ant 
Not 
sig 
0.36
1 
Not 
sig 
complications of the 
disease 
0.635 Not 
sig 
0.563 Not 
sig 
0.899 Not 
sig 
0.60
2 
Not 
sig 
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5.13 Relationship between the theoretical variables and the treatment 
compliance of total respondents 
In this section the following research question is discussed what is the relationship between the 
treatment compliance and the following variables among hypertension patients: perception of 
severity; perception of risk; perception of benefits; perception of barriers; internal factors; health 
care provider factors; cues to action? 
Person's correlation analysis was used to assess the relationship between independent variables 
(perception of severity; perception of risk; perception of benefits; perception of barriers; internal 
factors; health care provider factors; cues to action) and treatment compliance (dependent 
variable). Significant relationship was found between the treatment compliance and the 
perception of severity, perception of barriers and internal factors (Table 5.41). 
        Table 5.41 relationships between Theoretical variables and treatment compliance of total  
respondents 
Variable r  p-value significance 
Perception of severity 0.173 0.003 Significance 
perception of risk 0.062 0.285 not significance 
perception of benefits 0.60 0.300 not significance 
Perception of berries -0.249 0.000 Significance 
Perception of Internal factors 0.188 0.001 Significance 
Perception of health care provider factors 0.017 0.772 not significance 
cues to action 0.094 0.103 not significance 
  
Relationship between the theoretical variables and the treatment compliance of UNRWA 
respondents: 
Significant relationship was found between the treatment compliance and the perception of 
barriers and internal factors of the UNRWA respondents.The findings were as follows significant 
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relationship was noticed between treatment compliance and perception of barriers (r= -0.323 
p=0.001) Table (5.51). 
 
Table 5.42 relationships between Theoretical variables and treatment compliance of 
           UNRWA respondents 
Variable r  p-value significance 
Perception of severity 0.185 0.065 not significance 
perception of risk 0.102 0.311 not significance 
perception of benefits 0.041 0.685 not significance 
Perception of berries -0.323 0.001 significance 
Perception of Internal factors 0.254 0.011 significance 
Perception of health care provider factors -.0180 0.860 not significance 
cues to action 0.060 0.552 not significance 
 
Relationship between the theoretical variables and the treatment compliance of 
Government respondents 
Significant relationship was found between the treatment compliance and the perception of 
barriers and perception severity of the Government respondents. The findings were as follows 
significant relationship was noticed between treatment compliance and perception of barriers (r= 
0.262 p=0.008), perception of severity (r= 0.207 p= 0.039), cues to action (r=0.234 p= 0.019) 
(Table5.43). 
Table 5.43 relationships between Theoretical variables and treatment compliance of  
Government respondents. 
Variable  R  p-value significance 
Perception of severity 0.207 0.039  significance 
perception of risk -0.036 0.724 not significance 
perception of benefits 0.062 0.537 not significance 
Perception of berries -0.262 0.008 significance 
Perception of Internal factors 0.155 0.124 not significance 
Perception of health care provider factors 0.089 0.378 not significance 
cues to action 0.234 0.019  significance 
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Relationship between the theoretical variables and the treatment compliance of NGOs 
respondents 
Significant relationship was found between the treatment compliance and the perception of 
barriers and internal factors of the NGO's respondents. The findings were as follows table (5.44). 
Table 5.44 Relationships between Theoretical variables and treatment compliance of NGO  
respondents. 
Variable R  p-value significance 
Perception of severity 0.089 0.377 not significance 
perception of risk -0.018 0.072 not significance 
perception of benefits 0.120 0.234 not significance 
Perception of berries -0.225 0.024 significance 
Perception of Internal factors 0.263 0.008 significance 
Perception of health care provider factors .031 0.763 not significance 
cues to action -0.002 0.982 not significance 
 
Comparison of drug treatment and compliance between UNRWA, Government and NGO 
respondents: 
One way Anova test was done to compare the mean compliance of drug treatment between 
UNRWA, Government and NGO. NGO respondents showed significant relationship between the 
three groups (Table5.45). 
Table5.45 Relationship between treatment compliance between UNRWA, Government  
andNGO respondents 
 
Between  groups 
sum of squares df Mean square F sig 
1.992 2 .996 7.500 .001 
Within groups 39.445 297 .133   
total 41.437 299    
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Multiple comparison LSD test was done to show that NGO group has more compliance of drug 
treatment than UNRWA and Government groups(table5.46). 
Table 5.46 Mean difference between treatment compliance by clinics 
 
 
 
 
Comparison of lifestyle modifications and compliance between UNRWA, Government and    
NGO   respondents: 
     One way Anova test was done to compare the mean compliance oflifestyle modifications 
between UNRWA, Government and NGO respondents, there is a significant relationship 
between both UNRWA and Government to NGO which means that UNRWA and Government 
were more compliant of lifestyle modifications than NGOs (Table5.47). 
Table5.47 Relationship of lifestyle modification between UNRWA, Government  
and NGO respondents 
 
Between  groups 
sum of squares df Mean square F sig 
1.853 2 10.157 10.157 0.000 
Within groups 27.089 297    
total 28.942 299    
 
Multiple comparison LSD test was done to show that UNRWA and Government groups were 
more compliant of lifestyle modification than NGO group as showed in table (5.48) 
Clinic Mean difference 
UNRWA Government NGO 
UNRWA -----------   
Government 0.00143 ------------  
NGO 0.17357 0.17214 ----------- 
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5.14 Regression analysis between theoretical variables and treatment 
compliance 
This section discusses the last research question:Which of the following variables are predictor 
variables for treatment compliance? 
Socio-demographic variables; perception of severity, perception of risk; perception of benefits; 
perception of barriers; internal factors; health care provider factors and cues to action. 
Stepwise multiple regression analysis was performed on the variables (perception of severity, 
perception of risk; perception of benefits; perception of barriers; internal factors; health care 
provider factors and cues to action), to predict the relative contribution of each variable to 
treatment compliance. Due to small sample size, subgroup analysis of the biographical variables 
couldn’t be performed. The best predictive model involved the combination of three predictor 
variables: perception of barriers, perception of internal factors, and perception of severity 
(table5.49). 
 
 
 
Table 5.48 Mean difference between treatment compliance by clinic 
Clinic Mean difference 
UNRWA Government NGO 
UNRWA ------------   
Government -.04182 --------------  
NGO .14182 -.18364 --------------- 
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Table 5.49 Regression analysis summaries of predictor variables for treatment compliance of 
total respondents 
 
Model 
R R 
Square 
Adjust
ed R 
square 
Std. 
Error of 
the 
Estimate 
Change Statistics 
R 
Square 
Chang 
F 
Change 
df1 df2 Sig F 
Chang 
perception 
of barriers 
.249 6.2% .059 .25235 .062 19.752 1 298 .000 
perception 
of internal 
factors 
.304 9.2% .086 .24868 .030 9.865 1 297 .002 
perception 
of severity 
.327 10.7% .098 .24712 .014 4.763 1 296 .030 
 
The best predictive model of UNRWA respondents involved the combination of perception of 
barriers and perception of internal factors. (Table 5.50) 
Table 5.50 Regression analysis summaries of predictor variables for treatment compliance of 
UNRWA respondents 
 
Model 
R R 
Square 
Adjust
ed R 
square 
Std. 
Error of 
the 
Estimate 
Change Statistics 
R 
Square 
Chang 
F 
Change 
df1 df2 Sig F 
Chang 
perception 
of barriers 
.323 10.5% .095 .26454 .105 11.43
7 
1 98 .001 
perception 
of internal 
factors 
.382 14.6% .128 .25972 .041 4.668 1 97 .033 
 
The best predictive model of Government respondents involved the combination of perception of 
barriers and perception of cues to action (Table 5.51). 
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Table 5.51 Regression analysis summaries of predictor variables for treatment compliance of 
Government respondents 
 
 
Model 
 
 
R R 
Square 
Adjust
ed 
R 
square 
 
Std. 
Error of 
the 
Estimat 
Change Statistics 
R 
Square 
Chang 
F 
Change 
df1 df2 Sig. F 
Chang 
perception 
of barriers 
.262 6.9% 0.059 0.28520 0.069 7.230 1 98 0.008 
perception 
of cues to 
action 
.331 11.0% 0.091 0.28028 0.041 4.474 1 97 0.037 
 
The best predictive model of NGO's respondents involved the combination of perception of 
internal factors and perception of barriers. (Table 5.52) 
Table 5.52 Regression analysis summaries of predictor variables for treatment compliance NGOs 
respondents. 
 
Model 
R R 
Square 
Adjusted 
R square 
 
Std. 
Error of 
the 
Estimate 
Change Statistics 
R 
Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
perception of 
internal 
factors  
.263 6.9% 0.059 0.19387 0.069 7.256 1 98 0.008 
perception of 
barriers 
.351 12.3% 0.105 0.18912 0.054 5.974 1 97 0.016 
 
 
 
 
86 
 
 
 
 
 
Chapter six 
Discussion 
6.1 Introduction 
In this chapter, the researcher summarizes and discusses the findings of the research which 
consists of five questions. 
6.2 Compliance with Anti-hypertension Drug Treatment: 
Question 1: How compliant are the respondents with their hypertension drug regimen? 
The data obtained from the compliance with the medication regimen scale indicates that the total 
respondents were generally compliant with their medication regimens (mean 3.75);NGOs got the 
highest mean (mean3.87) followed by UNRWA and Governments respondents (mean 3.69) 
The researcher attributes this result to the type of health care provider, a mobile clinic, which 
provides the health service in fixed appointments and forces the NGO's patients to comply with 
their appointments. We can say that the NGO patients were not affected by frequent changes of 
the type or dose of their medications and medication side effects didn’t affect their compliance. 
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UNRWA and Government clinics are fixed clinics, so the patients can reach them and get their 
medication at any time which may affect their compliance to their appointments and may give a 
feeling of safety for the patients as they can get their medication at any time which may possibly 
decrease their compliance to their appointments.  
Most of UNRWA patients lived in the camp or close to the clinic, and that may decrease their 
compliance.  UNRWA health care policy (open day clinic) provides the patients with their 
medications on a daily basis, keeping in mind that the UNRWA hypertension patients have their 
own appointment system where they can get their medications.  
Government patients can get their medication when they finish their drugs since there is no 
appointment system for the hypertension patients at Government clinics except for the specialist 
every six months. These polices may decrease their compliance to drug treatments.  
Medication side effects were the second highest reason for non-compliance among 
UNRWArespondents, but this is not supported with evidence from their records. These results 
agree with Sabate study that an adverse effect of treatment have negative effects on compliance 
to hypertension treatment.Another reason was forgetfulness; this may be due to the respondent’s 
age since the elderly tend to have poor compliance because of memory loss and reduction in 
functional capabilities such as eyesight loss and decreased the ability of the hands to do activities 
such as bottle opening, these results agrees with Sabate study that the prevalence of cognitive 
and functional impairments in elderly patients increases their risk of poor adherence, also it 
agrees with Zyoud study which revealed that patients over the age of 68 years had lower median 
MMAS score than those less than 68 years. 
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Compliance with the medication regimen as reported by the UNRWA respondents was 72%who 
didn’t skip any doses in the last three days. These respondents were more compliant to their 
medication regimen than respondents from the Governmental clinic (68%) and the NGO's 
respondents(68%).This result may be due to the management and follow up program of the 
UNRWA system because visiting your clinic and meeting your doctor or health care provider 
gives you the chance to share them your needs and problems associated with disease and 
treatment and a way of detecting the early complications of hypertension to avoid the 
development of those complications. This result agrees with Wridate's study results that showed  
patients who visit their doctors every three months were (2.886) less compliant when compared 
to those who visited the doctor regularly every month (Wridat,2012). 
However, the above results differ from other studies such as WHO publications data about 
adherence to long term therapy of hypertension patients that varies between 50 and 70%.This 
variation is due to the use of different study methods. 
In literature medication side effects was a significant reason of non-compliance with medication 
regimen which also agrees with our study. 
6.3 Compliance with lifestyle modifications regimen 
Question 2: How compliant are the respondent with their lifestyle modification regimen? 
The data obtained from the compliance with lifestyle medication regimen (mean 3.15) of the 
total respondents indicates that the total respondents were generally compliant with lifestyle 
modifications. Government respondents got the highest mean (mean3.22) followed by UNRWA 
(mean3.18) while the less compliant were the NGOs respondents (3.04). 
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The researcher attributes this result to the culture of those patients who mostly live in the city 
and Bethlehem villages; however, they were more compliant to the recommended behaviors and 
the culture of losing weight is spread among them. The affordability of the physical clubs and 
dietitians may increase their compliance to those behaviors. 
UNRWA respondents were compliant in physical exercise. Dehaisha camp located on main 
street encourages walking; besides, there is a women sport center in the camp. 
The NGO's respondents were less compliant among the total respondents with lifestyle 
modifications; the researcher attributes this to their culture. They lived in urban area which was 
poor in physical activities and physical clubs.  
The clinical records of the UNRWA respondents reflect the lifestyle commitments of the 
patients. The patient’s records of Governments and NGOs do not have information about 
lifestyle modifications and concentrate on the drug regimen. This reflects the well-organized 
system of non-communicable diseases used by UNRWA according to WHO recommendations. 
The above results reflect the awareness of the respondents about their disease which agrees with 
Hashmi study that awareness is associated with higher adherence. Sabate study said that 
inadequate knowledge and skill in managing the disease have negative effects on compliance to 
hypertension treatment. 
6.4 Relationships between treatment compliance and socio-demographic 
factors 
Question 3: What is the relationship between compliance and the socio-demographic 
factors (age, gender, marital status, educational status, work status, monthly income); 
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physiological factors (weight); duration of illness; number of medication prescribed; doses 
of medication skipped; and alcohol intake? 
The results indicate that the total respondents who skipped one dose for more than three days 
were less compliant with their treatment medication (drug treatment and lifestyle modifications) 
than the respondents who skipped one dose for less than three days, so the hypertension patient 
who had skipped dosages were at risk of being inadequately compliant with their hypertension 
treatment. 
This study showed that UNRWA males, 32, who skipped one dose for more than three days 
might be particularly at risk of being inadequately compliant with their treatment while UNRWA 
females, 63, were more compliant with their treatment medication. The researcher attributes this 
result to nature of the female. The female is afraid for her life more than the male. Additionally, 
most of the females were unemployed, so they had enough time to visit the clinic to take their 
medication. This result agrees with Wridat's study and Sa’ed H.Zyoyed'swhich showed that the 
female gender was associated with a higher Morisky eight-item Medication Adherence Scale 
(MMAS) scoreand agrees with the Dessie study in Ethiopia which found that there was a 
significant association between sex and compliance level; men were found to be less adherent 
than women, also this finding is similar to the finding of a study done in India where men had 
almost threefold increase in risk of non-adherence compared to womenstudy but differs from 
Waleed Sweileh's which stated that there is no significant relationship between gender and rate 
of compliance.Another study found that compliance appears to be similar among men and 
women (O'Hanrahan & O'Malley). 
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Government respondents who were obese and who didn’t skip any doses were more compliant to 
their treatment regimen. The researcher attributes this result to the fact that obese patients realize 
that obesity is an important factor related to high blood pressure. 
43% of the NGOs respondents who had primary education and 21% who had no schooling and 
17% of the respondents who had secondary education were more compliant with their treatment 
medication regimen. This is different from another local study that was done by Wridate and 
indicates that the education didn’t affect the compliance. However, the al Najah study indicated 
that compliance increased as the level of education increased, also it agrees with Sabaté study 
which said that illiteracy is a risk factor of poor compliance;Mizuno Fujimoto study signifies that 
non-compliance was less prevalent among the more highly educated than among the less 
educated 
The unemployed patients (63%) were more compliant with their treatment medication regime. 
However, this study indicates that the unemployed were mostly females (56.7%). Thus, 
unemployed femaleshave more free time than employed people which can lead to them 
complying more with their medication regime. Moreover, they have the enough time to showup 
to their clinic appointments as scheduled. This result agrees with theMizuno, Fujimoto studyThat 
the compliance rate for patients with essential hypertension was significantly lower in patients 
with an occupation than in those who were unemployed, the compliance rate was significantly 
lower in patients engaged in physical labour than in patients engaged in office work and was 
significantly lower in patients working for a shifted time during the day than in patients working 
for a fixed time.This differs from theSabate study and WHO reports that claim unemployment is 
a risk factor of poor adherence. 
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6.5 Relationships between treatment compliance and perceptions: 
Question 4: What is the relationship between treatment compliance and the following 
variables: perception of severity, perception of risk, perception of benefits, perception of 
barriers, internal factors, health care provider, and cues to action? 
In this study, there was strong relationship between perception of barriers, internal factors and 
perception of severity with treatment compliance of the total respondents. 
 The data obtained of UNRWA and NGOs respondents in this study indicated that perception of 
barriers and perception of internal factors were significant with treatment compliance. Regarding 
UNRWA, NGOs, Governments respondents perception of barriers, the researcher attributes this 
result to the their belief that they can overcome those barriers and the benefits of complying to 
hypertension drug treatment and lifestyle modifications overweigh the consequence of non-
compliance. Their knowledge of the nature of this disease as a lifelong and incurable disease 
encouraged them to comply with treatment and overcome the barriers. The education programs 
and the good relationship between the respondents and their doctorsand health staff encouraged 
them to comply with their treatment. Cost is one of the most important barriers to medication 
compliance, but for the total respondents of this study UNRWA provides free services to the 
Palestinian refugees. Government respondents have health insurance, and Palestinian Medical 
Relief Society provides NGO respondents free medications. 
This result agrees with literature that the most important factor related to compliance is 
perception of barriers. 
  Perception of internal factors for UNRWA and NGO respondents was significant to compliance 
to treatment. The level of knowledge and the awareness of the disease are important in managing 
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it, UNRWA and NGOs clinics provides their clients with information through health education 
programs, brochures. The non-communicable disease program at UNRWA clinic concentrates on 
those patients and provides them with a lot of information about the disease and how to manage 
it. The nature of the UNRWA patients is that they can tolerate and take their own responsibility.  
Nearly half of UNRWA respondents and seventy percent of the NGO respondents believe that 
the doctor is primarily responsible to manage their hypertension which indicates that they don’t 
understand the sharing responsibility of the doctors and the patients. The respondents are aware 
when their body feels well and when it’s not healthy. Their health is determined by what they do 
and what they don’t do. They are in charge of their health and know how their medication works 
to keep their blood pressure under control. Many of the respondents think that the herbs can’t be 
replaced by their drug treatment while some think that herbs can replace their drug treatment. 
This is not so bad since the Palestinian culture believes in natural herbs as treatments. Also they 
faced problems in the management of hypertension, and the reading of blood pressure. This may 
be due to their old age. 
In this study, there was a significant relationship between the Government respondent’s 
compliance and  perception of severity, perception of barriers, and cues to action, It’s known that 
primary hypertension is asymptomatic and not curable (WHO 2003). This current research 
showed Government respondent’s high perception of severity of their hypertension and belief 
about seriousness of the disease which was based on medical information or knowledge, so most 
of them believe that their condition is serious which makes them comply to their treatment even 
if there are no symptoms. If there are symptoms, the Government's respondents accepted the 
advice from heath care providers. Feeling un-well encouraged the patients to be more compliant 
which indicates a   fear of the severity of the disease. The information from the internet was the 
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least significant element in encouraging the respondents due to the non-availability of the 
internet. The death of relatives also didn’t motivate the patients (65%), but this may be due to 
their religious culture. 
The Government respondents perceived positively the cues to action. They accepted the advice 
from doctors, nurses, and health care providers which indicates the importance of the the patient- 
doctor (health care provider) relationship in complying with the treatment. The respondent 
feeling unwell was an important cue of action for complying with their treatment regimen, and 
may be this due to the natural fear of being ill and dying. On the other side, most of the 
government respondents were not affected by the death of friend or relatives but this may be due 
to religious considerations and believes. 
6.6 Predictor variables of treatment compliance: 
The simple regression analysis performed on all study variables of the total respondents 
demonstrated that the combination of perception ofbarriers, perception of internal factors and 
perception of severity formed the best predictive model of treatment compliance. In this study, 
perception of barriers was the most significant variable on compliance and predict 6.2% of 
variations on treatment compliance (drug and lifestyle modifications) followed by perception to 
internal factors which predict 3% of the variations, followed by perception of severity. The three 
predictor variables predict 10.7% of the total variance and the remaining variances due to other 
variables not concluded in the study. 
Perception of barriers was the most significant predictor variable on compliance for UNRWA 
respondents which predict 10.5% of the variance followed by perception of internal factors 
which predict 14.6% of the variance. 
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Perception of barriers was the most significant predictor variable on compliance for Government 
respondents which predict 6.9% of the variance followed by perception cues to action which 
predict 11% of the variance. 
Perception of internal factors was the most significant predictor for the NGOs respondents which 
predict 6.9% of the variance followed by perception of barriers which predict 12.3% of the 
variance. 
 In this study, the total respondents who believed in the seriousness of hypertension or in the 
seriousness of leaving it untreated and held low perception of stated barriers and believed in his 
own ability to manage hypertension would be more compliant with their medication treatment 
and lifestyle modifications than those who don’t hold those perceptions.  
UNRWA respondents who held low perception of barriers and believed in their ability to manage 
hypertension will be more compliant with their medication treatment. 
Government respondents who held low perception of barriers in the presence of cues to action 
will be more compliant with their medication treatment. 
NGOs respondents who believed in their ability to manage hypertension and held low perception 
of barriers will be more compliant with their medication treatment. 
6.7 Conclusions  
In this study, the Health Belief Model was used to evaluate compliance behavior among 
hypertension patients at UNRWA, Government, and NGOs primary health care centers. Even 
with the acceptable compliance scores in the study, the results indicate the importance of this 
96 
 
study as many factors were unsatisfactory such as obesity, overweight, uncontrolled 
hypertension and co-morbidities. 
The respondents were convinced of the seriousness of the disease which affected their treatment 
compliance, and they believed that non-compliance lead to undesirable medical and social 
consequences which threaten the life of the patients.  They were sufficiently convinced of the 
benefits of complying with their treatment despite their belief that compliance with treatment 
will not decrease chance of dying regarding religious consideration. The patients believe thatthey 
are not responsible for management of their condition, and this may be because they don’t have 
the ability to do that which reflects the lack of communication and the sharing of information 
between health care provider and the patients. The patients admitted that the doctors didn’t 
explain how they could manage their blood pressure. The patients believe that advice from 
doctors motivated them to comply with their treatment, so this is a good point in helping to 
convince patients to comply with their treatment. 
The non-compliance behaviors which were revealed included failure to regularly monitor their 
blood pressure, comply with follow-up visit requirements, and honor their clinicappointments. 
An unacceptably high number of respondents also failed to ingest their medications as prescribed 
during the previous three days. 
The risk behaviors which were identified are insufficient physical exercise, relaxation, sleep, and 
failure to keep their weight under control. An unacceptable number of the respondents 
insufficiently complied with the dietary requirements of limiting their consumption of animal fat, 
salt, fast foods, and smoking cessation. 
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Findings of this study have wide ranging implications for health care professionals dealing 
directly with hypertension patients in the health centers and generally with the Ministry of 
Health, UNRWA and NGOs mangers to unite their efforts toward effective hypertension 
management in the whole country. 
6.8 Recommendations 
Recommendations for this study will focus on two sides. The first one is the clinical practice, and 
the second one is recommendations for further research.  
Recommendations for clinical practice 
The following recommendations for clinical practice are derivative of the findings: 
Doctors and nurses must educate hypertensive patients about their disease with specific emphasis 
on its causes, the severity of the disease, how their medications work and the consequences of 
non-compliance with treatment. Patients should be taught how to interpret their blood pressure 
readings. Doctors need to emphasize that the drug treatment is for life, dosage should not be 
skipped and that the medications should not be discontinued. Patients should be discouraged 
from relying on local herbs to treat their condition. 
Doctors and nurses need to emphasize the importance of compliance with their hypertension 
treatment despite the absence of symptoms. This includes complying with follow-up visits and 
honoring clinic appointments. It is necessary to stress the benefits of their treatment and their 
risks of developing complications.  
The doctors should move beyond these explanations by contributing towards the removal of the 
barriers which may compromise compliance. Special emphasis should be placed on reducing the 
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waiting times at the clinics, ensuring that medicines are available at all times, and regular in-
service training sessions for doctors. Contactand communication mechanisms should be 
introduced at the health centers to trace and monitor patients who do not comply with follow-up 
visits and clinic appointments. 
Health education campaigns concerning hypertension should be delivered through the mediums 
of radio, television, posters, and pamphlets. It is necessary to target patients and the community 
at large, especially family and friends of hypertensive patients. The health education message 
could be transported by persons who developed complications as a result of non-compliance and 
those who lost a precious one as a result of hypertension. 
This study has shown that most non-compliant patients are very likely to admit being so if 
interviewed by their doctors. Therefore, during consultation, doctors must inquire whether the 
patient is complying with prescribed medication and lifestyle modification regimens and if not 
steps must be taken to encourage compliance. 
This study has highlighted essential lifestyle behaviors to which patients should be motivated to 
comply. These are physical exercise, weight control and adequate sleep. Thus, health 
professionals must encourage their patients to have adequate sleep (6-8hours per day) and 
engage in moderate physical exercise lasting between 30 minutes and one hour on at least 3 to 5 
days per week. Exercise helps weight control and maintenance of normal blood pressure. 
Doctors are required to motivate patients to reduce their consumption of animal fat, fast foods, 
salt, and to quit smoking. This study found unacceptable high level of obesity among the 
respondents. Policies should be drawn at the national level to focus on diet and physical activity 
in order to control obesity and hypertension. 
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Patient support groups should be established in all districts as this would help compliant and 
non-compliant patients meet, interact and share experiences. 
With regards to the patient’s files at Government clinics, they were not separated, so it’s better to 
design separated files. 
For all clinics, it’s recommended to add an item about side effects of hypertension drugs.   
Recommendations for further research 
The following aspects require further research, the prevalence rate of hypertension and 
uncontrolled hypertension must be conducted in the country; such a survey would provide useful 
information for policy makers to evaluate medical situation and economic reasons. 
A study aimed at comparing the medication and the lifestyle modifications compliance patterns 
in patients attending private health care centers should be conducted. 
Qualitative research should be conducted to obtain much more detailed information about factors 
that could improve compliance. It is known that not all factors that affect compliance with 
medications and lifestyle modifications requirement were studied. 
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اﻗﺮار ﺑﺎﻟﻤﻮاﻓﻘﺔ ﻋﻠﻰ اﻟﻤﺸﺎرآﺔ ﻓﻲ اﻟﺒﺤﺚ
ﻋﺰﻳﺰي/ﻋﺰﻳﺰﺗﻲ اﻟﻤﺸﺎرك ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ 
ﺗﺤﻴﺔ طﻴﺒﺔ و ﺑﻌﺪ: 
أﻧﺎ اﻟﻄﺎﻟﺒﺔ  أﻣﻞ اﻟﻌﺰﻩ أﻗﻮم ﺑﻬﺬﻩ اﻟﺪراﺳﺔ وذﻟﻚ آﻤﺘﻄﻠﺐ ﻟﻨﻴﻞ درﺟﺔ اﻟﻤﺎﺟﺴﺘﻴﺮ ﻓﻲ اﻟﺴﻴﺎﺳﺎت 
واﻻدارة اﻟﺼﺤﻴﺔ ﻣﻦ ﺟﺎﻣﻌﺔ اﻟﻘﺪس –أﺑﻮدﻳﺲ وهﻲ ﺑﻌﻨﻮان اﻟﻌﻮاﻣﻞ اﻟﺘﻲ ﺗﺆﺛﺮ ﻋﻠﻰ اﻟﺘﺰام ﻣﺮﺿﻰ
 اﻧﻤﺎط اﻟﺴﻠﻮك ﻓﻲ ﻋﻴﺎدات اﻟﺼﺤﺔ اﻻوﻟﻴﺔ ﻓﻲ ﻣﻨﻄﻘﺔ ﺗﻌﺪﻳﻞارﺗﻔﺎع ﺿﻐﻂ اﻟﺪم ﺑﺘﻨﺎول ﻋﻼﺟﻬﻢ و
 . ﺑﻴﺖ ﻟﺤﻢ
اﻗﺒﻞ اﻟﻤﺸﺎرآﻪ ﻓﻲ هﺬا اﻟﺒﺤﺚ واﻟﺬي ﻳﻬﺪف اﻟﻰ ---------- اﻧﺎ اﻟﻤﻮﻗﻊ ادﻧﺎﻩ ---------------------
اﻟﺘﻲ ﺗﺆﺛﺮ ﻋﻠﻰ اﻟﺘﺰام اﻟﻤﺮﺿﻰ ﺑﻌﻼج ارﺗﻔﺎع ﺿﻐﻂ اﻟﺪم وﺗﻌﺪﻳﻞ ﻧﻤﻂ اﻟﺤﻴﺎة ﻓﻲ  ﺗﺤﺪﻳﺪ اﻟﻌﻮاﻣﻞ
 اﻟﺴﻠﻮك هﻮ أﻧﻤﺎط ﺗﻌﺪﻳﻞأن اﻻﻟﺘﺰام ﺑﺎﻟﻌﻼج وﺣﻴﺚ ﻋﻴﺎدات اﻟﺼﺤﺔ اﻻوﻟﻴﺔ ﻓﻲ  ﻣﻨﻄﻘﺔ ﺑﻴﺖ ﻟﺤﻢ
 ﻣﻦ أهﻢ اﻟﻌﻮاﻣﻞ اﻟﺘﻲ ﺗﺴﺎﻋﺪ اﻟﻤﺮﺿﻰ ﻋﻠﻰ ﺿﺒﻂ ﺿﻐﻂ اﻟﺪم ﻟﺪﻳﻬﻢ. 
 دﻗﻴﻘﺔ. وهﻲ 52هﺬﻩ اﻻﺳﺘﺒﺎﻧﺔ ﺗﺘﻜﻮن ﻣﻦ ﻣﺠﻤﻮﻋﺔ ﻣﻦ اﻻﺳﺌﻠﺔ وﺗﺤﺘﺎج ﺗﻌﺒﺌﺘﻬﺎ ﻣﺎ ﻻ ﻳﺰﻳﺪ ﻋﻦ 
ﻻهﺪاف ﺗﻌﻠﻴﻤﻴﺔ ﺑﺤﺘﻪ. 
واﺗﻌﻬﺪ ﺑﺎﻟﻤﺤﺎﻓﻈﺔ ﻋﻠﻰ ﺳﺮﻳﺔ اﻟﻤﻌﻠﻮﻣﺎت اﻟﻮاردة ﻓﻲ هﺬا اﻷﺳﺘﺒﻴﺎن ، وﻟﻚ اﻟﺤﻖ ﻓﻲ ﻗﺒﻮل او رﻓﺾ
اﻟﻤﺸﺎرآﺔ ﻓﻲ هﺬا اﻟﺒﺤﺚ. و اﺧﻴﺮا ﻓﺎﻧﻨﺎ ﻧﻮد ان ﻧﻨﻮﻩ اﻟﻰ اﻟﺴﺮﻳﺔ اﻟﺘﺎﻣﺔ ﺣﻮل هﻮﻳﺔ اﻟﺸﺨﺺ اﻟﺬي 
ﻗﺎم ﺑﺘﻌﺒﺌﺔ اﻻﺳﺘﺒﺎﻧﺔ ﻣﻀﻤﻮﻧﺔ ﻓﻲ هﺬا اﻟﺒﺤﺚ.  
                                                                                                 اﻟﺒﺎﺣﺜﺔ 
أﻣﻞ ﻣﺤﻤﻮد اﻟﻌﺰﻩ
                                                          .   --------------------------- اﻟﻤﺸﺎرك/ﻩﺗﻮﻗﻴﻊ
                                           ------------------------------------.                 اﻟﺘﺎرﻳﺦ
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  اﻟﻌﻮاﻣﻞ اﻟﺘﻲ ﺗﺆﺛﺮ ﻋﻠﻰ أﻟﺘﺰام اﻟﻤﺮﺿﻰ ﺑﻌﻼج ارﺗﻔﺎع ﺿﻐﻂ اﻟﺪم وﺗﻌﺪﻳﻞ ﻧﻤﻂ اﻟﺤﻴﺎة ﻓﻲ ﻋﻴﺎدات اﻟﺼﺤﺔ اﻻوﻟﻴﺔ ﻓﻲ  ﻣﻨﻄﻘﺔ ﺑﻴﺖ ﻟﺤﻢ
  -------------------اﻟﻤﺮﻳﺾ ﻗﻢر
 :ﻳﺘﻠﻘﻰ اﻟﻤﺮﻳﺾ ﻋﻼج ﺿﻐﻂ اﻟﺪم  ﻓﻲ
 ?ﻋﻴﺎدة اﻻﻏﺎﺛﺔ اﻟﻄﺒﻴﺔ       ?ﻋﻴﺎدة اﻟﺤﻜﻮﻣﺔ ?ﻋﻴﺎدةاﻟﻮآﺎﻟﺔ
  ﺑﻴﺎﻧﺎت اﻟﺴﻴﺮة اﻟﺬاﺗﻴﺔ(: أ)اﻻول ﻘﺴﻢاﻟ
 ------------------------- -:ﺿﻐﻂ اﻟﺪم -1
  .---- -----------------ﻣﺆﺷﺮ آﺘﻠﺔ اﻟﺠﺴﻢ- 4---------------------- (ﺳﻢ)اﻟﻄﻮل- 3------------------- (آﻐﻢ)اﻟﻮزن-2
 .-------------------- ؟ (ﺑﺎﻟﺴﻨﻮات) ﻌﻤﺮاﻟ -5
  :ﺟﻨﺲ اﻟﻤﺮﻳﺾ -6
  ?اﻧﺜﻲ      ?ذآﺮ 
  :اﻟﺤﺎﻟﺔ اﻻﺟﺘﻤﺎﻋﻴﺔ -7
  ?أرﻣﻞ       ?ﻣﻨﻔﺼﻞ    ?ﻣﻄﻠﻖ    ?ﻣﺘﺰوج     ?أﻋﺰب 
  :اﻟﻤﺆهﻞ اﻟﻌﻠﻤﻲ -8
( اﻋﺪادي+اﺑﺘﺪاﺋﻲ)ﻠﺔ  اﻟﺰاﻣﻴﺔ ﻣﺮﺣ              ?( ﻳﻌﺮف اﻟﻘﺮاءة واﻟﻜﺘﺎﺑﺔ ﺑﺪون اﻧﻬﺎء ﻣﺮﺣﻠﺔ ﺗﻌﻠﻴﻤﻴﺔ) ﻣﻠﻢ                        ?أﻣﻲ 
                         ?ﺑﻜﺎﻟﻮرﻳﻮس                          ?دﺑﻠﻮم ﻣﺘﻮﺳﻂ                    ?ﻣﺮﺣﻠﺔ ﺛﺎﻧﻮﻳﺔ                                                ?
  ?أﻋﻠﻰ ﻣﻦ ﺑﻜﺎﻟﻮرﻳﻮس 
  ﻃﺒﻴﻌﺔ ﻋﻤﻠﻚ ﺧﻼل اﺧﺮ ﺛﻼﺛﺔ ﺷﻬﻮر -9
                ?ﻣﺘﻘﺎﻋﺪ                 ?ﻃﺎﻟﺐ              ?ﻋﻤﻞ ﺧﺎص         ?ﻣﻮﻇﻒ ﻏﻴﺮ ﺣﻜﻮﻣﻲ            ?ﻣﻮﻇﻒ ﺣﻜﻮﻣﻲ 
  ?ﻻ ﻳﻌﻤﻞ 
  .ﻣﻌﺪل اﻟﺪﺧﻞ اﻟﺸﻬﺮي  ﻟﻠﻌﺎﺋﻠﺔ ﺧﻼل اﻟﺴﻨﺔ اﻟﻤﺎﺿﻴﺔ ﺑﺎﻟﺸﻴﻜﻞ -01
  ?ﻓﺄآﺜﺮ 0003                               ? 9992 -0002                           ? 9991 -0001                   ? 999 - ﺻﻔﺮ
 ﺑﺎﺻﺎﺑﺘﻜﺒﻀﻐﻂ دم ﻣﺮﺗﻔﻊ؟( ان ﻋﻨﺪك)آﻴﻒ ﻋﺮﻓﺖ  -11
 ?ﻏﻴﺮ ذﻟﻚ       ?اﻟﻌﻴﺎدة      ?ﻋﻨﺪ ﺻﺪﻳﻖ            ?اﻟﺼﻴﺪﻟﻴﺔ              ?ﻓﻲ اﻟﺒﻴﺖ          ?اﻟﻤﻤﺮض      ?اﻟﻄﺒﻴﺐ 
  ﻣﺘﻰ ﻋﻠﻤﺖ ﻷول ﻣﺮة ان ﺿﻐﻂ دﻣﻚ ﻣﺮﺗﻔﻊ؟ -21
  ?ﺧﻤﺲ ﺳﻨﻮات ﻓﺄآﺜﺮ        ?ارﺑﻊ ﺳﻨﻮات ﻓﺄآﺜﺮ      ?ﺛﻼث ﺳﻨﻮات ﻓﺄآﺜﺮ       ?ﺳﻨﺘﻴﻦ ﻓﺄآﺜﺮ    ?أآﺜﺮ ﻣﻦ ﺳﻨﺔ
 اﻟﻤﺸﺎآﻞ اﻟﺼﺤﻴﺔ اﻟﺘﻲ ﺗﺸﻜﻮ ﻣﻨﻬﺎ ﺑﺎﻻﺿﺎﻓﺔ ﻟﻀﻐﻂ اﻟﺪم ؟ -31
  ?ﻣﺸﺎآﻞ ﻓﻲ اﻟﻜﻠﻰ    ?ﺧﻠﻞ ﻓﻲ اﻟﻨﻈﺮ     ?اﻧﺘﻔﺎخ ﻓﻲ اﻟﻘﺪﻣﻲ  اﻧﺘﻔﺎخ ﻓﻲ اﻟﺴﺎﻗﻴﻦ     ?ﺷﻠﻞ ﻓﻲ اﻷﻃﺮاف      ?ﻣﺸﺎآﻞ ﻓﻲ اﻟﻘﻠﺐ 
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                              ?ﺿﻴﻖ ﻓﻲ اﻟﻨﻔﺲ ﻓﻲ وﻗﺖ اﻟﺮاﺣﺔ              ?ﺿﻴﻖ ﻓﻲ اﻟﻨﻔﺲ ﻋﻨﺪ ﺑﺬل ﻣﺠﻬﻮد         ?ذﺑﺤﺔ ﺻﺪرﻳﺔ --اﻻم ﻓﻲ اﻟﻘﻠﺐ 
  .?ﻏﻴﺮ ذﻟﻚ                                           ?ﻻﻳﻮﺟﺪ                                       ?ﻋﺪم اﻧﺘﻈﺎم ﻓﻲ دﻗﺎت اﻟﻘﻠﺐ     
  هﻞ ﺗﺘﻌﺎﻃﻰ دواء ﻟﻌﻼج ارﺗﻔﺎع ﺿﻐﻂ اﻟﺪم؟ -41
 ?ﻻ ?ﻧﻌﻢ 
 آﻢ ﻧﻮﻋﺎ ﻣﻦ اﻟﺪواء ﺗﺘﻌﺎﻃﻰ ﻟﻌﻼج ﺿﻐﻂ اﻟﺪم اﻟﻤﺮﺗﻔﻊ؟ -51
  ?أرﺑﻌﺔأآﺜﺮ ﻣﻦ ?أرﺑﻌﺔ ?ﺛﻼﺛﺔ                ?اﺛﻨﺎن  ?واﺣﺪ 
  آﻢ ﺟﺮﻋﺔ دواء ﺗﺘﻌﺎﻃﻰ ﻓﻲ اﻟﻴﻮم ﻟﻌﻼج ﺿﻐﻂ اﻟﺪم اﻟﻤﺮﺗﻔﻊ؟ -61
 ﻓﺄآﺜﺮ 6??5  4?3         ? 2?1?
  آﻢ ﺟﺮﻋﻪ ﻣﻦ اﻟﻌﻼج ﻟﻢ ﺗﺘﻌﺎﻃﺎهﺎ ﺧﻼل اﻻﻳﺎم اﻟﺜﻼﺛﺔ اﻟﻤﺎﺿﻴﻪ ؟ -71
  ?ﻓﻤﺎ ﻓﻮق 5?4?3?2?1?( وﻻ ﺟﺮﻋﻪ)ﺻﻔﺮ
  هﻞ ﺗﺪﺧﻦ ﺣﺎﻟﻴﺎ؟ -81
 ?ﻻ                ?ﻧﻌﻢ  
  ﻳﻮﻣﻴﺎ؟ آﻢ ﺳﻴﺠﺎرة ﺗﺪﺧﻦ -91
ﺳﻴﺠﺎرة ﻓﻤﺎ  02           ?ﺳﻴﺠﺎرة 91-51              ?ﺳﻴﺠﺎرة41-01                ?ﺳﺠﺎﺋﺮ 9-5                 ?ﺳﺠﺎﺋﺮ   4-1
  ?ﻓﻮق 
 هﻞ آﻨﺖ ﺗﺪﺧﻦ ﺳﺎﺑﻘﺎ؟ -02
  ?ﻻ     ?ﻧﻌﻢ   
  آﻢ ﺳﻴﺠﺎرة آﻨﺖ ﺗﺪﺧﻦ ﻳﻮﻣﻴﺎ؟ -12
ﺳﻴﺠﺎرة ﻓﻤﺎ  02            ?ﺳﻴﺠﺎرة 91- 51                ?ﺳﻴﺠﺎرة41- 01               ?ﺳﺠﺎﺋﺮ 9-5              ?ﺳﺠﺎﺋﺮ   4-1
  ?ﻓﻮق 
  آﻢ ﺳﻨﺔ دﺧﻨﺖ؟ -22
  ?أآﺜﺮ ﻣﻦ ﺧﻤﺲ ﺳﻨﻮات                 5?4?3?2?1?
  هﻞ ﺗﺘﻨﺎول اﻟﻜﺤﻮل؟-32
  ?ﻻ                 ?ﻧﻌﻢ  
  آﻢ ﺗﺴﺘﻬﻠﻚ ﻣﻦ اﻟﻜﺤﻮل ﻋﺎدة؟ -42
  ?آﺜﻴﺮا               ?ﻗﻠﻴﻼ                             ?ﻧﺎدرا                                ?ﻳﻮﻣﻴﺎ   
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  :ﻟﻠﻌﻼج( اﻻﻟﺘﺰام)اﻻﻣﺘﺜﺎل: اﻟﻘﺴﻢ اﻟﺜﺎﻧﻲ
  أﺑﺪا
  1
 
 ﻧﺎدرا
 2
  ﻏﺎﻟﺒﺎ
 3
 داﺋﻤﺎ
 4
  هﻞ
 1 (ﻣﻦ ﺣﻴﺚ  اﻟﺠﺮﻋﺔ واﻟﻮﻗﺖ ) دواﺋﻚ آﻤﺎ وﺻﻒ ﻟﻚﺗﺘﻨﺎول     
 2 ان ﺗﺘﻨﺎول دواءك ﺗﻨﺴﻲ    
 3 ﺗﻬﻤﻞ ﻓﻲ  ﺗﻨﺎول دواءك    
 4 ﻷﻧﻚ ﺷﻌﺮت ان ﺻﺤﺘﻚ ﺗﺤﺴﻨﺖ ﺘﻮﻗﻒ ﻋﻦ ﺗﻨﺎول دواءكﺗ    
 5 ﺑﻌﺪم اﻟﺘﺤﺴﻦﺘﻮﻗﻒ ﻋﻦ ﺗﻨﺎول دواءك ﻷﻧﻪ ﻳﺸﻌﺮك ﺗ    
 6 ﺘﻮﻗﻒ ﻋﻦ ﺗﻨﺎول دواءك ﻻﻳﻤﺎﻧﻚ ﺑﺄﻧﻪ ﻏﻴﺮ ﻓﻌﺎلﺗ    
 7 ﺘﻮﻗﻒ ﻋﻦ ﺗﻨﺎول دواءك ﻻﻧﻚ ﺗﺮﻳﺪ ان ﺗﺘﺠﻨﺐ اﻻدﻣﺎنﺗ    
 8 ﺗﻨﺎول دواءك ﻷﻧﻚ ﺗﺸﻌﺮ ﺑﺄﺛﺎر ﺟﺎﻧﺒﻴﺔ ﺳﻠﺒﻴﺔﻮﻗﻒ ﻋﻦ ﺘﺗ    
 9 ﺘﻮﻗﻒ ﻋﻦ ﺗﻨﺎول دواءك ﻷن اﻟﻄﺒﻴﺐ ﻳﻐﻴﺮ ﻧﻮع اﻟﺪواء آﺜﻴﺮاﺗ    
 01 ﻮﻗﻒ ﻋﻦ ﺗﻨﺎول دواءك ﻷن اﻟﻄﺒﻴﺐ ﻳﻐﻴﺮﺟﺮﻋﺔ اﻟﺪواء آﺜﻴﺮاﺘﺗ    
 11 اﻋﺸﺎب) ﺘﻮﻗﻒ ﻋﻦ ﺗﻨﺎول دواءك ﻷﻧﻚ ﺗﺮﻳﺪ ﺗﺠﺮﺑﺔ ادوﻳﺔ ﺑﺪﻳﻠﺔﺗ    
 21 ﻋﺒﻮة دواءك ﻗﺒﻞ ﻧﻔﺎذ اﻟﺪواء اﻟﻤﻮﺟﻮد ﻋﻨﺪك ﺗﺤﻀﺮ    
 31 ﻣﻮﻋﺪك ﻓﻲ اﻟﻌﺎدة آﻤﺎ هﻮ ﻣﻘﺮر ﻟﻚ ﻰﺗﺤﻀﺮ ﻋﻠ    
 41 .ﻣﺴﺠﻞ ﻋﻠﻴﻬﺎ ﻣﻮاﻋﻴﺪ اﻟﺤﻀﻮر اﻟﻰ اﻟﻌﻴﺎدﻩ( ﻣﺮﻳﺾ ﺿﻐﻂ  )ﻟﺪﻳﻚ ﺑﻄﺎﻗﺔ     
 
  اﻻﻣﺘﺜﺎل ﻟﺘﻌﺪﻳﻞ ﺳﻠﻮك وﻧﻤﻂ اﻟﺤﻴﺎة: اﻟﻘﺴﻢ اﻟﺜﺎﻟﺚ
  أﺑﺪا
 1
  ﻧﺎدرا
 2
  ﻏﺎﻟﺒﺎ
 3
  داﺋﻤﺎ
 4
 آﻢ
 1 ﺗﺪﺧﻦ    
 2 ﺗﺸﺮب آﺤﻮل    
 3 (ﺧﺮوف ﻣﺜﻼ/دﺳﻤﺔ)ﺗﺄآﻞ وﺟﺒﺔ ﻏﻨﻴﺔ ﺑﺎﻟﺪهﻮن اﻟﺤﻮاﻧﻴﺔ    
 4 ﺗﺄآﻞ ﺧﻀﺮوات    
 5 ﺗﺄآﻞ ﻓﻮاآﻬﻪ    
 6 ﺗﺄآﻞ وﺟﺒﺎت ﺳﺮﻳﻌﺔ    
 7 ﻣﻠﺢ ﻋﻠﻰ ﻃﻌﺎﻣﻚ (ﺗﻀﻴﻒ)ﺗﺮش    
 8 (رﻳﺎﺿﺔ)ﺗﻤﺎرس ﻧﺸﺎط ﺟﺴﻤﺎﻧﻲ    
 9 ول ﺗﺨﺴﻴﺲ وزﻧﻚﺎﺗﺤ    
01 ﺗﺴﺘﺮﺧﻲ    
11 آﺎﻓﻴﺎﺗﻨﺎم ﻧﻮﻣﺎ     
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  ادراك ﺷﺪة اﻟﻤﺮض: اﻟﻘﺴﻢ اﻟﺮاﺑﻊ
 
 
  ادراك ﻣﺨﺎﻃﺮ اﻟﻤﺮض: اﻟﻘﺴﻢ اﻟﺨﺎﻣﺲ
ﻻ اواﻓﻖ 
  1ﺑﺸﺪة
 
  ﻻ اواﻓﻖ
 2
  اواﻓﻖ
 3
  أواﻓﻖ ﺑﺸﺪة
 4
ﺔ ﻧﺘﻴﺠﺔ ﻻرﺗﻔﺎع ﺿﻐﻂ اﻻﺗﻴﺧﻄﺮوﻗﻮع  اﻻﻣﻮر  (ي/ﺑﺘﺸﻮف)آﻴﻒ ﺗﻨﻈﺮ
 دﻣﻚ؟
 -1 ﺑﺴﻜﺘﺔ دﻣﺎﻏﻴﺔ اﺻﺎبان     
 2 ﺑﺨﻠﻞ ﻓﻲ اﻟﻨﻈﺮان اﺻﺎب     
 3 اﺻﺎب ﺑﻤﺸﺎآﻞ ﻗﻠﺒﻴﺔان     
 4 ﺑﻤﺸﺎآﻞ ﻓﻲ اﻟﻜﻠﻰان اﺻﺎب     
 5 ﺑﺸﻠﻞان اﺻﺎب     
 6 ﻋﺒﺌﺎ ﻋﻠﻰ اﻟﻌﺎﺋﻠﺔان اﺻﺒﺢ     
 7 ان ﺗﺘﺄﺛﺮ ﻣﻬﻨﺘﻚ ﺳﻠﺒﻴﺎ    
 8 ان ﺗﺆﺛﺮ ﻋﻠﻰ ﺣﻴﺎﺗﻲ اﻟﻌﺎﺋﻠﻴﺔ ﺳﻠﺒﻴﺎ    
 9 اان ﺗﺆﺛﺮ ﻋﻠﻰ ﻋﻼﻗﺎﺗﻲ اﻻﺟﺘﻤﺎﻋﻴﺔ ﺳﻠﺒﻴﺎ    
 
  ادراآﺎﻟﻔﻮاﺋﺪ: ﺎﻟﺴﺎدساﻟﻘﺴﻤ
 
ﻏﻴﺮ ﻣﻔﻴﺪة 
 1ﻣﻄﻠﻘﺎ
ﻣﻔﻴﺪة ﻧﻮﻋﺎ 
   2ﺎﻣ
  ﻣﻔﻴﺪة
 3
ﻣﻔﻴﺪة 
   4ﻟﻠﻐﺎﻳﺔ
 
 آﻴﻒ ﺗﻨﻈﺮون اﻟﻰ ﻓﻮاﺋﺪ اﻻﻣﺘﺜﺎل ﻟﻌﻼج اﻟﻄﺒﻴﺐ
 1 ﺗﺤﺖ اﻟﺴﻴﻄﺮةﻳﺒﻘﻲ ﺣﺎﻟﺘﻲ اﻟﻤﺮﺿﻴﺔ     
 2 ﻧﻮﻋﻴﺔ ﺣﻴﺎﺗﻲ ﻳﺤﺴﻦ     
 3 (----- رﺣﻠﺔ, ﻣﺸﻮار) ﻳﺰﻳﺪ ﺷﻌﻮري ﺑﺎﻟﺮﻓﺎهﻴﺔ    
 4 (- -- ,اﻟﻜﻠﻰ, اﻟﺠﻠﻄﺎت,أﻣﺮاض اﻟﻘﻠﺐ) اﻟﻤﺮضﻳﺤﻤﻴﻨﻲ ﻣﻦ ﻣﻀﺎﻋﻔﺎت     
 5 ﻳﺠﻨﺒﻨﻲ زﻳﺎدة اﻻﻋﺒﺎء اﻟﻤﺎﻟﻴﺔ ﻟﻌﻼج ﻣﻀﺎﻋﻔﺎت اﻟﻤﺮض    
 6 (اﻟﻮﻓﺎﻩ)ﻳﻘﻠﻞ ﻓﺮص اﻟﻤﻮت     
 7 (راﺣﺔ ﺑﺎل)ﻳﻌﻄﻴﻨﻲ ﺳﻼم ﻋﻘﻠﻲ     
  
  
  ﻻ اواﻓﻖ
  ﺑﺸﺪة
 1
  ﻻ اواﻓﻖ
 2
  اواﻓﻖ
 3
  اواﻓﻖ ﺑﺸﺪة
 4
 :اﻟﻰ أي ﺣﺪ ﺗﻮاﻓﻖ ﻋﻠﻰ اﻟﺠﻤﻞ اﻻﺗﻴﻪ
 1 ادرك ﺧﻄﻮرة ﺣﺎﻟﺘﻲ اﻟﻤﺮﺿﻴﺔ    
 2 ﻻ اآﺘﺮث ﻟﺤﺎﻟﺘﻲ اﻟﻤﺮﺿﻴﺔ ﻟﻌﺪم وﺟﻮد اﻋﺮاض ﻟﻠﻤﺮض    
 3 ﺑﺴﺒﺐ وﺟﻮد اﻋﺮاض اﻟﻤﺮض ﻣﻦ ﺣﺎﻟﺘﻲ اﻟﻤﺮﺿﻴﺔ اﻧﺎ ﻗﻠﻖ    
 4 ﻌﺪم وﺟﻮد اﻋﺮاض ﻟﻠﻤﺮضﻟاﻧﺎ اﻋﺘﻘﺪ اﻧﻨﻲ ﺷﻔﻴﺖ     
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  ادراك اﻟﻌﻮاﺋﻖ: اﻟﺴﺎﺑﻊ ﻘﺴﻢاﻟ
ﻻ ﻳﻮﺟﺪ 
  ﺗﺄﺛﻴﺮ
 1
ﺗﺄﺛﻴﺮ 
  ﻣﻨﺨﻔﺾ
 2
ﺗﺄﺛﻴﺮ 
  وﺳﻂ
 3
  ﺗﺄﺛﻴﺮ
  ﻋﺎﻟﻲ
 4
  
  ؟:اﻟﺘﺰاﻣﻚ ﺑﺘﻨﺎول دواﺋﻚﺎﻟﻌﻮاﻣﻞ اﻻﺗﻴﺔ ﺗﻌﻴﻖ ﻤﻨأﻳ
 
 1 ﻓﻌﺎﻟﻴﺔ اﻟﺪواء ﻋﻠﻰ اﺳﺘﻘﺮار ﺿﻐﻂ دﻣﻲ    
 2 (ة اﻧﻚ ﺗﺸﻔﻲ/ﻣﺜﻼ ﻋﻨﺪك اﻣﻞ ﻳﺎ ﺣﺞ)ﻗﻠﺔ اﻟﺪاﻓﻌﻴﺔ ﺗﺠﺎﻩ ﺷﻔﺎﺋﻲ ﻣﻦ اﻟﻤﺮض    
 3 ﻻ ﻳﻮﺟﺪ اﻟﻮﻗﺖ اﻟﻜﺎﻓﻲ ﻟﻤﻤﺎرﺳﺔ اﻟﺮﻳﺎﺿﺔ    
 4 اﻟﻨﻈﺎم اﻟﻐﺬاﺋﻲ    
 5 اﻳﻘﺎف اﻟﺘﺪﺧﻴﻦ    
 6 (ﻗﻠﺔ اﻟﻮﻗﺖ اﻟﻼزم ﻟﻼﺳﺘﺮﺧﺎء)اﻻﺳﺘﺮﺧﺎء    
 7 ﻣﺸﺎآﻞ ﻓﻲ اﻟﻨﻮم ﺪكﻋﻨ    
  
  
  
  اﻟﻌﻮاﻣﻞ اﻟﺪاﺧﻠﻴﺔ: اﻟﻘﺴﻢ اﻟﺜﺎﻣﻦ
ﻻ اواﻓﻖ 
  ﺑﺸﺪة
 1
  ﻻ اواﻓﻖ
 2
  ﻣﻮاﻓﻖ
 3
اواﻓﻖ 
  ﺑﺸﺪة
 4
  :اﻻﺗﻴﺔاﻟﻰ أي ﻣﺪى ﺗﻮاﻓﻖ ﻋﻠﻰ اﻟﺠﻤﻞ 
  
 
 1 (ﻣﺮﺿﻲ)ﻔﻬﻢ ﻃﺒﻴﻌﺔ ﺣﺎﻟﺘﻲﺗا    
 2 ﻔﻬﻢ ﺳﺒﺐ ارﺗﻔﺎع ﺿﻐﻂ دﻣﻲﺗا    
 3 ﻋﻠﻰ ﺿﻐﻂ دﻣﻲﻓﻲ اﻟﻤﺤﺎﻓﻈﺔ ادوﻳﺘﻲ دور ﻔﻬﻢ ﺗا    
 4 اﺗﻨﺎول دواﺋﻲ آﻤﺎ هﻮ ﻣﻮﺻﻮف ﻟﻲ ﺿﺮورة ﻔﻬﻢﺗا    
 5 .اﻋﺮف ﻣﺎ ﻋﻠﻰ ﻋﻤﻠﻪ ﻟﻠﻤﺤﺎﻓﻈﺔ ﻋﻠﻰ ﺿﻐﻂ دﻣﻲ ﺗﺤﺖ اﻟﺴﻴﻄﺮة    
 6 اﻓﻬﻢ ﻣﻌﻨﻰ ﻗﺮاءة ﺿﻐﻂ دﻣﻲ    
 7 اﻟﻤﻮﺻﻮﻓﺔاﻋﺘﻘﺪ اﻧﻨﻲ اﺳﺘﻄﻴﻊ ان اﻋﺎﻟﺞ ﺿﻐﻂ اﻟﺪم ﺑﺎﻻﻋﺸﺎب اﻟﻤﺤﻠﻴﺔ وﻟﻴﺲ ﺑﺎﻻدوﻳﺔ     
 8 ﻟﺪي اﻟﻘﺪرة ﻻﺗﺪﺑﺮ ﻣﻊ ﺿﻐﻂ دﻣﻲ    
 9 ﺿﻐﻂ دﻣﻲ ﻋﻨﻀﺒﻂ اﻧﺎ اﻟﻤﺴﺆول اﻻول    
 01 ﺿﻐﻂ دﻣﻲﻋﻦ ﺿﺒﻂ ﻃﺒﻴﺒﻲ هﻮ اﻟﻤﺴﺆول اﻻول     
 11 (اﻟﺠﺴﻤﻴﺔ) اﻧﺎ اﻟﻤﺴﺆول ﻋﻦ ﺻﺤﺘﻲ اﻟﺒﺪﻧﻴﺔ    
 21 .ﺗﺘﺤﺪد ﺑﻤﺎ اﻋﻤﻞ وﺑﻤﺎ ﻻ اﻋﻤﻞ( اﻟﺠﺴﻤﻴﺔ)ﺻﺤﺘﻲ اﻟﺒﺪﻧﻴﺔ     
 31 ﻋﻨﺪﻣﺎ ﻳﻜﻮن ﺟﺴﻤﻲ ﻣﺮﺗﺎحاﻋﺮف اﻧﺎ     
 41 ﻋﻨﺪﻣﺎ ﻻ ﻳﻜﻮن ﺟﺴﻤﻲ ﻣﺮﺗﺎحاﻻﺣﻆ ﻓﻮرا     
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  اﻟﻌﻮاﻣﻞ اﻟﻤﺮﺗﺒﻄﺔ ﺑﻤﺰودي اﻟﺨﺪﻣﺎت اﻟﺼﺤﻴﺔ: اﻟﻘﺴﻢ اﻟﺘﺎﺳﻊ
  
  
  
  ﻣﺤﻔﺰات اﻟﻌﻤﻞ واﻻﻟﺘﺰام: اﻟﻘﺴﻢ اﻟﻌﺎﺷﺮ
ﻻ اواﻓﻖ 
  ﺑﺸﺪة
 1
  ﻻ اواﻓﻖ
 2
  اواﻓﻖ
 3
اواﻓﻖ 
  ﺑﺸﺪة
 4
 :م ﺑﻌﻼج ﺿﻐﻂ اﻟﺪمهﺬﻩ اﻟﺪواﻓﻊ  ﺷﺠﻌﺘﻚ ﻋﻠﻰ اﻻﻟﺘﺰاأي ﻣﻦ 
 1 اﻟﺒﺮاﻣﺞ اﻟﺘﻠﻔﺰﻳﻮﻧﻴﺔ ﻋﻦ ﺿﻐﻂ اﻟﺪم    
 2 ﻋﻦ ﺿﻐﻂ اﻟﺪم( اﻟﺮادﻳﻮ)ﺑﺮاﻣﺞ اﻟﻤﺬﻳﺎع    
 3 اﻟﻨﺼﻴﺤﺔ ﻣﻦ اﻻﺻﺪﻗﺎء    
4 اﻟﻨﺼﻴﺤﺔ ﻣﻦ ﻃﺒﻴﺒﻲ    
 5 (اﺧﺼﺎﺋﻲ اﻟﺘﻐﺬﻳﺔ-ة/اﻟﻤﺮﺷﺪ-ة/اﻟﻤﻤﺮض)ﻧﺼﻴﺤﺔ اﻟﻌﺎﻣﻠﻴﻦ اﻟﺼﺤﻴﻴﻦ     
 6 اﻟﻨﺼﻴﺤﺔ ﻣﻦ اﻓﺮاد اﻟﻌﺎﺋﻠﺔ    
 7 ﺻﺪﻳﻖ او ﻗﺮﻳﺐ  ﻧﺘﻴﺠﺔ ﻟﻀﻐﻂ اﻟﺪمﻣﻮت     
 8 ﻗﺮاءة ﻣﺠﻠﺔ او ﺟﺮﻳﺪة    
 9 ﻣﻌﻠﻮﻣﺎت ﻣﻦ اﻻﻧﺘﺮﻧﺖ    
 01 ﻣﻦ اﻟﻤﻠﺼﻘﺎت اﻟﺼﺤﻴﺔ اﻟﻤﻌﺮوﺿﺔ    
 11 ﻣﻨﺸﻮرات اﻟﻤﻌﻠﻮﻣﺎت اﻟﺼﺤﻴﺔ اﻟﻤﻌﻄﺎة ﻟﻲ    
 21 ﻋﻨﺪﻣﺎ اﺷﻌﺮ ﺑﺄﻧﻨﻲ ﻟﻴﺲ ﻋﻠﻰ ﻣﺎ ﻳﺮام    
  
 
 
ﻻ اواﻓﻖ 
  ﺑﺸﺪة
 1
  ﻻ اواﻓﻖ
 2
  اواﻓﻖ
 3
اواﻓﻖ 
  ﺑﺸﺪة
 4
اﻟﻰ أي ﻣﺪى ﺗﻮاﻓﻖ ﻋﻠﻰ هﺬﻩ اﻟﺠﻤﻞ
 1 وﻗﺖ اﻻﻧﺘﻈﺎر ﻓﻲ اﻟﻌﻴﺎدة ﻣﻘﺒﻮل    
 2 (ﺧﺒﻴﺮ)اﻟﻄﺒﻴﺐ اﻟﺬي ﻳﻌﺎﻟﺠﻨﻲ ﻓﻲ اﻟﻌﻴﺎدة ﻣﺘﻤﺮس    
 3 اﻧﺎ اﺛﻖ ﺑﻄﺒﻴﺒﻲ    
 4 اﻟﻄﺒﻴﺐ ﺻﺒﻮر ﻣﻌﻲ    
 5 اﻟﻄﺒﻴﺐ ﻳﻌﺎﻣﻠﻨﻲ ﺑﺎﺣﺘﺮام    
 6 ﻳﻌﺎﻣﻠﻨﻲ ﺑﺎﺣﺘﺮام( ة/اﻟﻤﺮﺷﺪ/اﻟﻤﻤﺮﺿﺔ)اﻟﻌﺎﻣﻠﻴﻦ اﻟﺼﺤﻴﻴﻦ    
 7 اﻟﻄﺒﻴﺐ ﻳﺴﺘﻤﻊ اﻟﻰ ﻣﺨﺎوﻓﻲ    
 8 اﻟﻄﺒﻴﺐ ﻳﺘﻔﻬﻢ ﻣﺨﺎوﻓﻲ    
 9 ﻋﻦ  ﺣﺎﻟﺘﻲاﻟﻄﺒﻴﺐ ﻳﺸﺮح ﻟﻲ     
 01 اﻟﻄﺒﻴﺐ ﻳﺸﺮح ﻟﻲ آﻴﻒ اﺗﻌﺎﻳﺶ ﻣﻊ ﺿﻐﻂ دﻣﻲ    
 11 اﻟﻌﻼج ﻣﺘﻮﻓﺮ ﻋﻨﺪﻣﺎ اﺣﺘﺎﺟﻪ    
 21 اﻟﻌﻼج اﻟﺬي اﺗﻠﻘﺎﻩ ﻓﻲ اﻟﻌﻴﺎدة ﻓﻌﺎل    
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ﺘﺅﺜﺭ ﻋﻠﻰ ﺍﻻﻤﺘﺜﺎل ﻟﻠﻌﻼﺝ ﺒﺎﻟﻌﻘﺎﻗﻴﺭ ﻭﺘﻐﻴﻴﺭ ﻨﻤﻁ  ﺍﻟﺤﻴﺎﺓﻓﻲ ﻋﻴﺎﺩﺍﺕ ﺍﻟﺭﻋﺎﻴﺔ ﺍﻟﺼﺤﻴﺔ ﺍﻷﻭﻟﻴﺔ  ﺍﻟﺘﻲﺍﻟﻌﻭﺍﻤل 
 ﻓﻲ ﻤﺤﺎﻓﻅﺔ ﺒﻴﺕ ﻟﺤﻡ
  ﺍﻤل ﻤﺤﻭﺩ ﻴﻭﻨﺱ ﺍﻟﻌﺯﻩ: ﺍﻋﺩﺍﺩ
 ﺍﻟﺩﻜﺘﻭﺭ ﻤﺤﻤﺩ ﺸﺎﻫﻴﻥ: ﺍﺸﺭﺍﻑ
 ﻣﻠﺨﺺ اﻟﺪراﺳﺔ
ﺍﺭﺘﻔﺎﻉ  ﻤﻥ ﻗﻀﺎﻴﺎ ﺍﻟﺼﺤﺔ ﺍﻟﻌﺎﻤﺔ، ﻭﺍﻻﻤﺘﺜﺎل ﻟﻌﻼﺝ ﻫﺎﻤﻪ ﻴﻌﺩ ﻋﻼﺝ ﺍﺭﺘﻔﺎﻉ ﻀﻐﻁ ﺍﻟﺩﻡ ﺘﺤﺩﻴﺎ ﻫﺎﻤﺎ ﻭﻗﻀﻴﺔ
ﻀﻐﻁ ﺍﻟﺩﻡ ﻫﻭ ﻭﺍﺤﺩ ﻤﻥ ﺃﻫﻡ ﺍﻟﻌﻭﺍﻤل ﺍﻟﺘﻲ ﺘﺅﺜﺭ ﻓﻲ ﺍﻟﺴﻴﻁﺭﺓ ﻋﻠﻰ ﺍﺭﺘﻔﺎﻉ ﻀﻐﻁ ﺍﻟﺩﻡ ﻭﺤﻴﺙ ﺍﻨﻪ ﻻ ﻴﻭﺠﺩ 
  .ﺩﺭﺍﺴﺎﺕ ﻜﺎﻓﻴﺔ ﻟﻬﺫﻩ ﺍﻟﻘﻀﻴﺔ ﻓﻲ ﻓﻠﺴﻁﻴﻥ ﻤﺎ ﺩﻓﻌﻨﺎ ﻟﻠﻘﻴﺎﻡ ﺒﻬﺫﺍ ﺍﻟﺒﺤﺙ
ﻭﺘﻌﺩﻴل ﺘﻘﻴﻴﻡ ﺍﻟﻌﻭﺍﻤل ﺍﻟﺘﻲ ﺘﺅﺜﺭ ﻋﻠﻰ ﺍﻻﻤﺘﺜﺎل ﻟﻠﻌﻼﺝ ﺒﺎﻟﻌﻘﺎﻗﻴﺭ ﺍﻟﺨﺎﻓﻀﺔ ﻟﻠﻀﻐﻁ ﺇﻟﻰ ﺍﻟﺩﺭﺍﺴﺔ ﻫﺩﻓﺕ ﻫﺫﻩ 
ﻨﻤﻁ ﺍﻟﺤﻴﺎﺓ ﻭﻫﺫﻩ ﺍﻟﻌﻭﺍﻤل ﻫﻲ ﺒﻴﺎﻨﺎﺕ ﺍﻟﺴﻴﺭﺓ ﺍﻟﺫﺍﺘﻴﺔ، ﻭﺇﺩﺭﺍﻙ ﻤﺨﺎﻁﺭﺍﻟﻤﺭﺽ، ﻭﺍﺩﺭﺍﻙ ﺸﺩﺓ  ﺍﻟﻤﺭﺽ 
ﻭﻤﺤﻔﺯﺍﺕ ﺍﻟﻌﻤل ﻤﻊ ﻤﺯﻭﺩﻱ , ﻭﺍﺩﺭﺍﻙ ﻓﻭﺍﺌﺩﺍﻟﻌﻼﺝ ﻭﺍﺩﺭﺍﻙ ﺍﻟﻌﻭﺍﻤل ﺍﻟﺩﺍﺨﻠﻴﺔ ﻭﺍﺩﺭﺍﻙ ﻤﻌﻭﻗﺎﺕ ﺍﻟﻌﻼﺝ 
ﺍﺕ ﺍﻟﺭﻋﺎﻴﺔ ﺍﻟﺼﺤﻴﺔ ﺍﻟﺭﻋﺎﻴﺔ ﺍﻟﺼﺤﻴﺔ ﻟﻤﺭﻀﻰ ﺍﺭﺘﻔﺎﻉ ﺍﻟﻀﻐﻁ ﺍﻟﺩﻡ ﺍﻟﻔﻠﺴﻁﻴﻨﻴﻴﻥ ﺍﻟﺫﻴﻥ ﻴﺘﺭﺩﺩﻭﻥ ﻋﻠﻰ ﻋﻴﺎﺩ
 .ﺍﻷﻭﻟﻴﺔ ﻓﻲ ﻤﺤﺎﻓﻅﺔ ﺒﻴﺕ ﻟﺤﻡ
ﻤﺸﺎﺭﻙ ﻤﻥ ﻤﺭﻀﻰ ﺍﺭﺘﻔﺎﻉ  003ﺠﺭﻴﺕ ﺩﺭﺍﺴﻪ ﻭﺼﻔﻴﻪ  ﻤﻘﻁﻌﻴﺔ ﻋﻠﻰ ﻋﻴﻨﺔ ﻋﺸﻭﺍﺌﻴﺔ ﺘﺘﻜﻭﻥ ﻤﻥ ﻭﻗﺩ ﺃ
ﺍﻟﺤﻜﻭﻤﺔ، ﻭﻋﻴﺎﺩﺍﺕ ﺍﻟﻤﺠﺘﻤﻊ ﺍﻟﻤﺩﻨﻲ، ﻭﺫﻟﻙ ﺒﺎﺴﺘﺨﺩﺍﻡ ﺍﻻﺴﺘﺒﻴﺎﻥ ﻋﻴﺎﺩﺍﺕ ﺍﻷﻭﻨﺭﻭﺍ، ﻭ ﻋﻴﺎﺩﺍﺕ ﻀﻐﻁ ﺍﻟﺩﻡ ﻓﻲ
% 001ﺍﺕ ﻭ ﺘﻡ ﺍﻟﻠﻘﺎﺀ ﺒﻬﻡ ﻭﺠﻬﺎﹰ ﻟﻭﺠﻪ ، ﻭﻗﺩ ﻜﺎﻥ ﻤﻌﺩل ﺍﻻﺴﺘﺠﺎﺒﺔ ﺍﻟﻤﻐﻠﻕ ﺍﻟﺫﻴﻥ ﻴﻌﺘﻤﺩ ﻋﻠﻰ ﻨﻤﻭﺫﺝ ﺍﻟﻤﻌﺘﻘﺩ
ﻓﻲ ﺠﻤﻴﻊ ﺍﻟﻌﻴﺎﺩﺍﺕ، ﻭﻟﻘﺩ ﺘﻡ ﺘﺤﻠﻴل ﺍﻟﺒﻴﺎﻨﺎﺕ ﺒﺎﺴﺘﺨﺩﺍﻡ ﺒﺭﻨﺎﻤﺞ ﺍﻟﺤﺯﻡ ﺍﻹﺤﺼﺎﺌﻴﺔﺍﻹﺼﺩﺍﺭ ﺍﻟﺘﺎﺴﻊ ﻋﺸﺭ ﻟﻘﻴﺎﺱ 
  .ﺍﻻﻟﺘﺯﺍﻡ ﺒﺎﺴﺘﺨﺩﺍﻡ ﻤﻘﻴﺎﺱ ﻟﻴﻜﺭﺕ ﺍﻟﺭﺒﺎﻋﻲ
ﻭ ﻤﻥ ﺒﻴﻥ ﻤﺠﻤﻭﻉ . ﻜﺎﻨﻭﺍ ﺫﻜﻭﺭﺍﹰ%( 3.43)ﻤﻥ ﺍﻟﻤﺸﺎﺭﻜﻴﻥ ﻜﺎﻨﻭﺍ ﺇﻨﺎﺜﺎ %( 6.56)ﺍﻥ   ﺔﺍﻟﺩﺭﺍﺴﻭﻗﺩ ﺒﻴﻨﺕ 
%( 1.76)، ﻭ  ﻤﻀﺎﻋﻔﺎﺕ ﺍﻟﻤﺭﺽ ﻻ ﻴﻭﺠﺩ ﻋﻨﺩﻫﻡ ﺃﻱ ﻨﻭﻉ ﻤﻥ%( 6.23)ﺍﻟﻤﺴﺘﺠﻴﺒﻴﻥ ﻟﻼﺴﺘﻁﻼﻉ ﺘﺒﻴﻥ ﺃﻥ 
ﺃﻨﻭﺍﻉ ﻋﻼﺠﻴﺔ  3-1ﻤﻥ  ﻴﺘﻨﺎﻭﻟﻭﻥﺘﺒﻴﻥ ﺃﻥ ﻋﻨﺩﻫﻡ ﻤﺸﻜﻠﺔ ﺃﻭ ﺃﻜﺜﺭ ﻟﻬﺎ ﻋﻼﻗﺔ ﺒﺎﺭﺘﻔﺎﻉ ﻀﻐﻁ ﺍﻟﺩﻡ، ﻭﻏﺎﻟﺒﻴﺘﻬﻡ 
ﺠﺭﻋﺎﺕ ﻤﻥ  3- 1 ﺘﻨﺎﻭﻟﻭﻥﻴ%( 1.99)ﺇﻱ ﺠﺭﻋﺔ ﺩﻭﺍﺌﻴﺔ ﻭ  ﻴﺘﻨﺎﻭﻟﻭﻻ %( 7.0)، ﺒﻴﻨﻤﺎ %( 69)ﻤﻥ ﺍﻟﺩﻭﺍﺀ 
ﺍﻜﺩﻭﺍ ﺍﻨﻬﻡ ﺍﻟﺘﺯﻤﻭ ﺒﺘﻨﺎﻭل ﺍﻟﺠﺭﻋﺎﺕ ﻤﻥ ﻤﺠﻤﻭﻉ ﺍﻟﺫﻴﻥ ﺃﺠﺎﺒﻭﺍ ﻋﻠﻰ ﺍﻻﺴﺘﻁﻼﻉ %( 3.96)ﻭ . ﺍﻟﺩﻭﺍﺀ ﻴﻭﻤﻴﺎﹰ
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ﻟﻡ ﻴﻠﺘﺯﻤﻭ ﺒﺘﻨﺎﻭل ﻋﺩﺩ ﺍﻟﺠﺭﻋﺎﺕ %( 7.03)ﺨﻼل ﺍﺨﺭ ﺜﻼﺙ ﺍﻴﺎﻡ ﻤﻥ ﺍﻟﺩﺭﺍﺴﻪ ﻭ  ﺍﻟﺩﻭﺍﺌﻴﻪ ﻜﻤﺎ ﻭﺼﻔﺕ ﻟﻬﻡ
 .ﺍﻟﻤﺤﺩﺩﻩ
ﻼﻗﺔ ﻗﻭﻴﺔ ﺫﺍﺕ ﺩﻻﻟﺔ ﺇﺤﺼﺎﺌﻴﺔ ﺒﻴﻥ ﺍﻻﻟﺘﺯﺍﻡ ﺒﺎﻟﻌﻼﺝ  ﻭﻋﺩﻡ ﺘﻨﺎﻭل ﺍﻟﺠﺭﻋﺎﺕ ﺨﻼل ﺍﺨﺭ ﺘﺒﻴﻥ ﺍﻥ ﻫﻨﺎﻟﻙ ﻋ
-p)ﻭﺍﺩﺭﺍﻙ ﺍﻟﻤﻌﻭﻗﺎﺕ (300.0 = eulav-p)، ﻭﺍﺩﺭﺍﻙ ﺨﻁﻭﺭﺓ ﺍﻟﻤﺭﺽ (000.0 = eulav-p)ﺜﻼﺙ ﺍﻴﺎﻡ
  .(100.0 = eulav-p)ﻭﺍﺩﺭﺍﻙ ﺍﻟﻌﻭﺍﻤل ﺍﻟﺩﺍﺨﻠﻴﺔ (000.0 = eulav
ﺘﻡ ﺍﺴﺘﻁﻼﻉ ﺭﺃﻴﻬﻡ ﻜﺎﻥ ﻫﻨﺎﻟﻙ ﻋﻼﻗﺔ ﺫﺍﺕ ﺩﻻﻟﺔ ﺇﺤﺼﺎﺌﻴﺔ ﺒﻴﻥ  ﺃﻤﺎ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻤﺭﻀﻰ ﻭﻜﺎﻟﺔ ﺍﻟﻐﻭﺙ  ﺍﻟﻠﺫﻴﻥ
ﻭﻋﺩﻡ ﺘﻨﺎﻭل ﺍﻟﺠﺭﻋﺎﺕ ﺍﻟﺩﻭﺍﺌﻴﻪ ﻓﻲ ﺍﻷﻴﺎﻡ ﺍﻟﺜﻼﺙ  (530.0= eulav-p)ﺍﻻﻟﺘﺯﺍﻡ ﺒﺎﻟﻌﻼﺝ ﻭﺠﻨﺱ ﺍﻟﻤﺭﻀﻰ
 eulav-p)ﺔﻭﺍﺩﺭﺍﻙ ﺍﻟﻌﻭﺍﻤل ﺍﻟﺩﺍﺨﻠﻴ (100.0= eulav-p)ﻭﺍﺩﺭﺍﻙ ﺍﻟﻤﻌﻭﻗﺎﺕ(530.0= eulav-p)ﺍﻷﺨﻴﺭﺓ 
 (110.0 =
 ﻟﻤﺭﻀﻰ ﺍﻟﺤﻜﻭﻤﻪ ﻓﻘﺩ ﺘﺒﻴﻥ ﺍﻥ ﻫﻨﺎﻙ ﻋﻼﻗﻪ ﺫﺍﺕ ﺩﻻﻟﻪ ﺍﺤﺼﺎﺌﻴﻪ ﺒﻴﻥ ﺍﻻﻟﺘﺯﺍﻡ ﺒﺎﻟﻌﻼﺝ ﻭ ﻭﻋﺩﻡﻭﺍﻤﺎ ﺒﺎﻟﻨﺴﺒﻪ 
 = eulav-p)ﻭﻗﻴﺎﺱ ﻜﺘﻠﺔ ﺍﻟﺠﺴﻡ(000.0 = eulav-p)ﺘﻨﺎﻭل ﺍﻟﺠﺭﻋﺎﺕ ﺍﻟﺩﻭﺍﺌﻴﻪ ﻓﻲ ﺍﻷﻴﺎﻡ ﺍﻟﺜﻼﺙ ﺍﻷﺨﻴﺭﺓ 
 = eulav-p)ﻭﺍﺩﺭﺍﻙ ﺍﻟﻤﻌﻭﻗﺎﺕ  (930.0 = eulav-p)ﻭﺍﺩﺭﺍﻙ ﺨﻁﻭﺭﺓ ﺍﻟﻤﺭﺽ (310.0
 .(910.0 = eulav-p)ﻭﻤﺤﻔﺯﺍﺕ ﺍﻟﻌﻤل(800.0
ﺃﻤﺎ ﻓﻴﻤﺎ ﻴﺨﺹ ﻤﺅﺴﺴﺎﺕ ﺍﻟﻤﺠﺘﻤﻊ ﺍﻟﻤﺩﻨﻲ ﻜﺎﻥ ﻫﻨﺎﻙ ﻓﻘﺩ ﺘﺒﻴﻥ ﺍﻥ ﻫﻨﺎﻙ ﻋﻼﻗﻪ ﺫﺍﺕ ﺩﻻﻟﻪ ﺍﺤﺼﺎﺌﻴﻪ ﺒﻴﻥ 
-p)ﻭ ﺍﻟﻤﺴﺘﻭﻯ ﺍﻟﻤﻬﻨﻲ ﻟﻠﻤﺭﻀﻰ( 730.0 = eulav-p)ﻭ ﺍﻟﻤﺴﺘﻭﻯ ﺍﻟﺘﻌﻠﻴﻤﻲ ﻟﻠﻤﺭﻀﻰ ﺍﻻﻟﺘﺯﺍﻡ ﺒﺎﻟﻌﻼﺝ  
 = eulav-P). ﻭﺍﺩﺭﺍﻙ ﺍﻟﻌﻭﺍﻤل ﺍﻟﺩﺍﺨﻠﻴﻪ  (420.0= eulav-p)ﻭﺍﺩﺭﺍﻙ ﺍﻟﻤﻌﻭﻗﺎﺕ (30.0 = eulav
 (800.0
ﺇﻥ ﺃﻓﻀل ﺍﻟﻤﺘﻐﻴﺭﺍﺕ ﻟﻠﺘﻨﺒﺅﺒﺎﻻﻟﺘﺯﺍﻡ  ﺒﺎﻟﻌﻼﺝ ﻋﻨﺩ ﻜل ﺍﻟﺫﻴﻥ ﺘﻡ ﺍﺴﺘﻁﻼﻉ ﺭﺃﻴﻬﻡ ﻜﺎﻨﺕ ﺇﺩﺭﺍﻙ ﺍﻟﻤﻌﻭﻗﺎﺕ ﺍﻤﺎﻡ 
ﺍﻟﻤﺭﺽ ﻭﺍﺩﺭﺍﻙ ﺨﻁﻭﺭﺓ ﺍﻟﻤﺭﺽ ﺒﺎﻻﻀﺎﻓﻪ ﻻﺩﺭﺍﻙ ﺍﻟﻤﻌﺘﻘﺩﺍﺕ ﺍﻟﺩﺍﺨﻠﻴﺔ ،ﺒﺎﻟﻨﺴﺒﻪ ﻟﻤﺭﻀﻰ ﻭﻜﺎﻟﺔ ﺍﻟﻐﻭﺙ ﻓﻘﺩ 
ﺒﺅﻴﺔ ﻟﻼﻤﺘﺜﺎل ﻟﻠﻌﻼﺝ ﻫﻲ ﺍﺩﺭﺍﻙ ﺍﻟﻤﻌﻭﻗﺎﺕ ﺍﻤﺎﻡ ﺍﻟﻤﺭﺽ ﻭﺇﺩﺭﺍﻙ ﺍﻟﻌﻭﺍﻤل ﻜﺎﻨﺕ ﺃﻓﻀل ﺍﻟﻤﺘﻐﻴﺭﺍﺕ ﺍﻟﺘﻨ
 .ﺍﻟﺩﺍﺨﻠﻴﺔ
ﺍﻤﺎ ﻤﺭﻀﻰ ﺍﻟﺤﻜﻭﻤﺔ  ﻓﻘﺩ ﻜﺎﻨﺕ ﺃﻓﻀل ﺍﻟﻤﺘﻐﻴﺭﺍﺕ ﻟﻠﺘﻨﺒﺅﺒﺎﻻﻟﺘﺯﺍﻡ  ﺒﺎﻟﻌﻼﺝ ﻫﻲ ﺍﺩﺭﺍﻙ ﺍﻟﻤﻌﻭﻗﺎﺕ ﺍﻤﺎﻡ 
 .ﺍﻟﻤﺭﺽ ﻭﺍﺩﺭﺍﻙ ﻤﺤﻔﺯﺍﺕ ﺍﻟﻌﻤل
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ﺘﻨﺒﺅﺒﺎﻻﻟﺘﺯﺍﻡ  ﺒﺎﻟﻌﻼﺝ ﻫﻲ ﺍﺩﺭﺍﻙ ﻭﺍﻤﺎ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻤﺭﻀﻰ  ﺍﻟﻤﻨﻅﻤﺎﺕ ﻏﻴﺭ ﺍﻟﺤﻜﻭﻤﻴﺔ ﻜﺎﻨﺕ ﺃﻓﻀل ﺍﻟﻤﺘﻐﻴﺭﺍﺕ ﻟﻠ
  .ﺍﻟﻤﻌﻭﻗﺎﺕ ﺍﻤﺎﻡ ﺍﻟﻤﺭﺽ ﻭﺍﺩﺭﺍﻙ ﺍﻟﻌﻭﺍﻤل ﺍﻟﺩﺍﺨﻠﻴﺔ
ﺍﻟﻰ ﺍﻥ ﺍﻫﻡ ﺍﻟﻌﻭﺍﻤل ﺍﻟﺘﻲ ﺘﺅﺜﺭ ﻋﻠﻰ ﺍﻟﺘﺯﺍﻡ ﺍﻟﻤﺭﻀﻰ ﺒﺨﻁﺔ ﺍﻟﻌﻼﺝ ﻜﺎﻨﺕ ﻋﺩﻡ ﺘﻨﺎﻭﻟﻬﻡ  ﻭﺨﻠﺼﺘﻬﺫﻫﺎﻟﺩﺭﺍﺴﺔ
ﻟﺠﺭﻋﺎﺘﻬﻡ ﺍﻟﺩﻭﺍﺌﻴﻪ ﻓﻲ ﺍﺨﺭ ﺜﻼﺙ ﺍﻴﺎﻡ ﻤﻥ ﺍﻟﺩﺭﺍﺴﻪ ﻭﺠﻨﺱ ﺍﻟﻤﺭﻀﻰ ﻭﻜﺘﻠﺔ ﺍﻟﺠﺴﻡ ﻭﺍﻟﻤﺴﺘﻭﻯ ﺍﻟﺘﻌﻠﻴﻤﻲ 
ﻭﺍﻟﻤﻬﻨﻲ ﻭﻜﺫﻟﻙ ﺍﺩﺭﺍﻙ ﺍﻟﻤﺭﻀﻰ ﻟﺸﺩﺓ ﺍﻟﻤﺭﺽ ﻭﻗﺩﺭﺘﻬﻡ ﻋﻠﻰ ﺘﺨﻁﻲ ﺍﻟﻤﻌﻭﻗﺎﺕ ﺍﻤﺎﻡ ﺍﻟﻤﺭﺽ ﻭﺍﻟﻌﻭﺍﻤل 
  .  ﻪ ﻟﻠﻤﺭﺽ ﻤﻥ ﺤﻴﺙ ﻤﻌﺭﻓﺘﻬﻡ ﻟﻁﺒﻴﻌﺔ ﺍﻟﻤﺭﺽ ﻭﻤﺤﻔﺯﺍﺕ ﺍﻟﻌﻤل ﺍﻟﺘﻲ ﺘﺸﺠﻊ ﻋﻠﻰ ﺍﻻﻟﺘﺯﺍﻡﺍﻟﺩﺍﺨﻠﻴ
ﺍﻟﻰ ﺍﻥ ﺍﻻﻏﻠﺒﻴﻪ ﻤﻥ ﻤﺭﻀﻰ ﺍﻟﻀﻐﻁ ﺍﻟﺫﻴﻥ ﺸﺎﺭﻜﻭ ﻓﻲ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﻪ ﻜﺎﻨﻭ ﻤﻠﺘﺯﻤﻴﻥ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻭﺨﻠﺼﺕ 
ﺤﻴﺙ ﺘﺒﻴﻥ ﺍﻥ ﺍﻟﻤﺭﻀﻰ ﺍﻟﺫﻴﻥ ﻴﺘﻠﻘﻭﻥ ﺒﺨﻁﺔ ﻋﻼﺠﻬﻡ ﺴﻭﺍﺀ ﺒﺘﻨﺎﻭل ﺍﻻﺩﻭﻴﻪ ﺍﻭ ﺒﺘﻐﻴﻴﺭ ﻨﻤﻁ ﺍﻟﺤﻴﺎﻩ ﻟﺩﻴﻬﻡ 
ﻋﻼﺠﻬﻡ ﻓﻲ ﻋﻴﺎﺩﺍﺕ ﺍﻟﻤﺠﺘﻊ ﺍﻟﻤﺩﻨﻲ ﻜﺎﻨﻭ ﺍﻜﺜﺭ ﺍﻟﺘﺯﺍﻤﺎ ﺒﺨﻁﺔ ﻋﻼﺠﻬﻡ ﺍﻟﺩﻭﺍﺌﻴﻪ ﻤﻥ ﻤﺭﻀﻰ ﺍﻟﻌﻴﺎﺩﺍﺕ 
ﺍﻟﺤﻜﻭﻤﻴﻪ ﻭﺍﻟﻭﻜﺎﻟﻪ ﺒﻴﻨﻤﺎ ﻜﺎﻥ ﺍﻟﺘﺯﺍﻡ ﻤﺭﻀﻰ ﺍﻟﻭﻜﺎﻟﻪ ﻭﺍﻟﺤﻜﻭﻤﻪ ﺍﻋﻠﻰ ﻤﻥ ﺤﻴﺙ ﺍﻟﺘﺯﺍﻤﻬﻡ ﺒﺘﻐﻴﻴﺭ ﺴﻠﻭﻙ ﻭﻨﻤﻁ 
  .ﺍﻟﺤﻴﺎﻩ ﻤﻥ ﻤﺭﺽ ﻋﻴﺎﺩﺍﺕ ﺍﻟﻤﺠﺘﻤﻊ ﺍﻟﻤﺩﻨﻲ
  .ﺭﺘﻔﺎﻉ ﻀﻐﻁ ﺍﻟﺩﻡ؛ ﺘﻌﺩﻴل ﻨﻤﻁ ﺍﻟﺤﻴﺎﺓ؛ ﺍﻟﻌﻼﺝ ﺒﺎﻟﻌﻘﺎﻗﻴﺭﺍﻻﻤﺘﺜﺎل ﻟﻠﻌﻼﺝ؛ ﺍ: ﺔﺍﻟﻜﻠﻤﺎﺕ ﺍﻟﻤﻔﺘﺎﺤﻴ
 
  
 
 
 
